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ABSTRACT 
Chocolate liquor is the source of antioxidant flavanols (catechin and epicatechin) and 
methylxanthines (caffeine and theobromine) found in dark chocolate. Factors that can 
influence the flavanol and methylxanthine concentration. of dark chocolate investigated in 
this study include the amount of chocolate liquor added, alkalization, and cacao bean 
genus. The purpose of this study was to quantify flavanols and methylxanthines in 
different dark chocolates from Legacy Chocolates with different weight percentages of 
chocolate liquor and different cacao bean genera, Criollo and Forastero. Chocolate 
samples were analyzed by reverse-phase high performance liquid chromatography 
(HPLC). Results indicated that the greater the percentage of chocolate liquor added to the 
final product, the more flavanol antioxidants present. When comparing chocolates with 
similar weight percentages, the Forastero genus had a significantly greater (p < 0.05) 
flavanol concentration than the Criollo genus. The Criollo genus resulted in a 
significantly greater (p < 0.05) caffeine content in dark chocolate when compared to a 
product prepared with similar weight percentages of chocolate liquor from the Forastero 
genus. Conversely, the Forastero genus produced a chocolate that was significantly 
greater (p < 0.05) in theobromine when compared to a Criollo product with similar 
weight percentages of chocolate liquor. Alkalization processing did not appear to affect 
catechin, epicatechin, caffeine, or theobromine concentrations in chocolates with similar 
weight percentages of chocolate liquor. Commercial brand chocolates were analyzed for 
comparison. 
Acknowledgments 
Thank you, Dr. Rohrer for your encouragement over the last two years. Thank you, Dr. 
Ondrus for having enthusiasm about the study and spending a lot of time providing 
HPLC assistance. Thanks Connie Galep, your support and encouragement means a lot to 
me. Thank you, Mike Roberts for donating chocolate samples and taking time to answer 
many questions. Thank you, family and friends for all of your support. 
TABLE OF CONTENTS 
. . 
ABSTRACT ................................................................................................................ 11 
List of Tables ............................................................................................................ vii 
... 
List of Figures .......................................................................................................... vlll 
Chapter I: Introduction ............................................................................................... 1 
.......................................................................................... Statement of the Problem 3 
................................................................................................. Purpose of the Study 4 
Assumptions of the Study .......................................................................................... 4 
................................................................................................... Definition of Terms 5 
..................................................................................... Chapter 11: Literature Review 6 
Chapter 111: Methodology ......................................................................................... 38 
.......................................................................... Subject Selection and Description 38 
Instrumentation .................................................................................................... 42 
Data Analysis .......................................................................................................... 50 
Limitations .............................................................................................................. 50 
......................................................................... Chapter IV: Results and Discussion 51 
.......................... Calculation of Catechin. Epictechin, Caffeine. and Theobromine 54 
.................................................. Legacy Chocolates Medallions and TrufJle Shells 57 
........................................................... Means Comparison and Statistical Analysis 59 
.............................................................................................. Chapter V: Conclusion 78 
Recommendations ................................................................................................... 80 
References ............................................................................................................... 82 
............................................................ Appendix A: Catechin Standard Curve 93 
List of Tables 
Table 1 : Legacy Chocolates Variety Corresponding to Percent Chocolate Liquor. 
..................................................... Alkali Processing. and Tree Genus 39 
Table 2: Commercial Chocolate Variety Corresponding to Percent Chocolate 
........................................... Liquor. Alkali Processing. and Tree Genus 40 
............................................... Table 3 : Standard Mixture Solutions Concentrations 41 
Table 4: Mobile Phase Gradient Separation Conditions ........................................... 43 
.......................................... Table 5: Retention Times and Peak Area Ratios 52 
Table 6: Average Methylxanthine and Polyphenol Concentrations (mg/L) at 278 
........................................................................................................... and 290 nm 53 
Table 7: Methylxanthine and Polyphenol Concentrations per 40g Serving Size ..... 55 
Table 8: Methylxanthine and Polyphenol Concentrations (mglg) of Dark 
................................................................................. Chocolates 56 
Table 9: Flavanol and Methylxanthine Concentration per Legacy Chocolates 
Medallion and Truffle Shell Serving Sizes ........................................................ 58 
List of Figures 
........................................................ Figure 1 : Cocoa Bean Roasting Flow Diagram 10 
..................................................................................................... Figure 2: Caffeine 15 
......... ................................................................................... Figure 3: Theobromine ; 15 
...................................................... Figure 4: Flavonoid Diphenylpropane Structure 25 
............................................................................................... Figure 5: (-t)-catechin 25 
........................................................................................ Figure 6: (-)-epicatechin 26 
...................... Figure 7: Procyanidin Dimer (4-8 linkage, epicatechin monomers) 26 
Figure 8: Catechin UV-spectra ................................................................................. 44 
........................................................... Figure 9: Epicatechin UV-spectra 45 
............................................................. Figure 10: Caffeine UV-spectra 46 
....................................................... Figure 1 1 : Theobromine UV-spectra 47
.......................................... Figure 12: Chromatogram of Standard Mixture 48 
.................................... Figure 13: Legacy Chocolates 73.5% Chromatogram 49 
........ Figure 14: Mean Catechin Concentrations (mgl40 g) for Legacy Chocolates 61 
Figure 15: Mean Epicatechin Concentrations (mgl40 g) for Legacy 
................................................................................... Chocolates 62 
Figure 16: Mean Monomer Flavanols (mgl40 g, catechin and epicatechin) for all 
.................................................................................................. Chocolate Types 63 
Figure 17: Mean Catechin Concentrations (mgl40 g) for all Chocolate Types ....... 66 
Figure 18: Mean Epicatechin Concentrations (mgl40 g) for all Chocolate Types ... 68 
Figure 19: Mean Caffeine Concentrations (mgl40 g) for all Chocolate Types ........ 74 
Figure 20: Mean Theobromine Concentrations (mgl40 g) for all Chocolate 
Types.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ... . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ... . . -77 
Chapter I: Introduction 
Dark chocolate, also referred to as sweet chocolate, differs from other types of 
chocolate based upon the level of chocolate liquor added by weight to the final product. 
Chocolate liquor is the product attained by grinding the solid contents of the cacao 
(cocoa) bean, including the cocoa butter. The amount of chocolate liquor in a chocolate 
product is often referred to as the percentage of cocoa or cacao-derived ingredients per 
weight. 
In the United States, the Food and Drug Administration (FDA) has regulated the 
level of chocolate liquor to be at least 15% by weight for any chocolate product to be 
labeled as "dark or sweet chocolate" (Food and Drug Administration, 2003). 
Increasingly, many commercially sold dark chocolates are packaged with a label stating 
the percentage of cocoa-derived ingredients by weight. 
Chocolate liquor is the source of antioxidant polyphenols that are present in dark 
chocolate, cocoa, and other chocolate products prepared from chocolate liquor (Natsume 
et al., 2000). Since chocolate liquor contains polyphenols, it would be expected that the 
polyphenol content of chocolate would depend on the percent of chocolate liquor added 
to the finished product. However, a greater percentage of chocolate liquor may not 
always represent an increased polyphenol content in the finished chocolate product. 
Factors that affect the final polyphenol content of a finished chocolate product include 
the cacao bean variety, amount of chocolate liquor, amount of milk solids, alkalization 
processing, and cacao bean fermentation (Adamson et al., 1999; Natsume et al., 2000). 
Polyphenols are a group of antioxidants most universally found in the human diet 
(Scalbert, Johnson, & Saltrnarsh, 2005). They are widely distributed throughout the plant 
kingdom and typical dietary sources include fruit, vegetables, tea, coffee, red wine, 
grains, and chocolate. The polyphenols present in chocolate liquor, cocoa, and dark 
chocolate are classified as flavonoids. Flavonoids, such as catechin and epicatechin, are 
classified as flavon-3-01 monomer units (flavanols); their oligomers are classified as 
procyanidins (Lazarus, Hammerstone, Adamson, & Schmitz, 200 1). An abundance of 
polyphenol antioxidants in the diet has been associated with a decreased risk of 
developing chronic diseases, such as cardiovascular disease (Grassi et al., 2005; Rein et 
al., 2000a, 2000b; Wang et al., 2000) and cancer (Arteel et al., 2000; Keeny et al., 2004; 
Yarnagishi et al., 2002a). Studies have demonstrated that cocoa has more polyphenols 
and flavonoids than green tea and red wine, therefore, resulting in a higher antioxidant 
activity once ingested (Lee, Kim, Lee, & Lee, 2003). 
Other compounds present in chocolate, caffeine and theobromine, are a class of 
methylxanthines that have been widely quantified in the literature. Methylxanthines have 
known physiological effects in the body such as central nervous system stimulation, 
cardiac muscle stimulation, relaxation of smooth muscle (especially bronchial muscle), 
and diuretic effects (Apgar & Tarka, 1999; Gilbert, 2004). 
Like polyphenols, chocolate liquor is also the source of methylxanthines that are 
present in dark chocolate. In addition to the percentage of chocolate liquor added to the 
finished product, the caffeine and theobromine content of dark chocolate depend on a 
variety of factors, including cacao bean genus, cacao bean maturity, and cacao bean 
fermentation conditions (Apgar & Tarka, 1999). Therefore, the associated health effects 
due to methylxanthine consumption from chocolate may differ by chocolate brand or 
type. 
The concentration of catechin, epicatechin, caffeine, and theobromine present in 
dark chocolate can be quantified by high performance liquid chromatography (HPLC). 
By analyzing the concentration of these compounds in different chocolate products, the 
health effects associated with their consumption can be reviewed in regards to the amount 
of each compound present per serving size. Since the amount of each compound may 
differ by brand, it is important to quantify the concentrations in a variety of dark 
chocolate products to observe the degree of variance. 
Statement of the Problem 
Flavanol monomers, such as catechin and epicatechin, and methylxanthines such 
as caffeine and theobromine have been extensively quantified in different types of 
chocolates. However, the comparison and quantification of flavanol monomers and 
methylxanthines from different sources of dark chocolate ( ~ o v e @ ,  Ghirardelli, 
~ershey's@, Legacy Chocolates, and Lindt) have not previously been conducted. 
Legacy Chocolates sells two main types of finished dark chocolate samples, 
medallions and truffles. Five types of raw chocolate with different weight percentages of 
chocolate liquor (4.1%, 58.5%, 60%, 73.5%, and 100%) are used to produce Legacy 
Chocolates' medallions and the truffle shell. These raw chocolate products were tested 
using reverse-phase HPLC to quantify levels of catechin, epicatechin, caffeine, and 
theobromine. 
For comparison, commercial brand solid dark chocolate products ( ~ o v e @ ,  
Ghirardelli, ~ e r s h e ~ ' s @ ,  and Lindt) were also analyzed. HPLC testing was conducted at 
the UW-Stout Chemistry Department, 3'* floor Jarvis Hall Science Wing during the 
spring 2006 semester. 
Purpose ofthe Study 
The purpose of this study was to quantify flavanols (catechin and epicatechin) and 
methylxanthines (caffeine and theobromine) in different dark chocolate samples from 
Legacy Chocolates by HPLC. The specific objectives were to: 
1) Develop an HPLC method for detecting monomer flavanols (catechin and 
epicatechin) and methylxanthines (caffeine and theobromine) simultaneously 
from solid dark chocolate samples; 
2) Quantify the concentration of catechin, epicatechin, caffeine, and theobromine in 
Legacy Chocolates dark chocolate samples containing five different weight 
percentages of chocolate liquor: 41%, 58.5%, 60%, 73.5%, and 100% (chocolate 
liquor); 
3) Determine the pure medallion and truffle shell monomer flavanol/methylxanthine 
concentration in chocolates containing 4 1 %, 58.5%, 60%, 73.5%, and 100% 
weight percentages of chocolate liquor available from Legacy Chocolates. 
4) Quantify and compare the monomer flavanol and methylxanthine content of 
Legacy Chocolates with four commercial dark chocolates ( ~ o v e @ ,  Ghirardelli, 
~ e r s h e ~ ' s @ ,  and Lindt). 
Assumptions 
Flavanols and methylxanthines were assumed to be present in all varieties of dark 
chocolate samples. In addition to the analytes of interest being present in all of the dark 
chocolates, the samples with the greater percentages of chocolate liquor by weight were 
assumed to contain a greater concentration of flavanols/methylxanthines than the dark 
chocolates containing a lower amount of chocolate liquor by weight. 
Definition of Terms 
The following terms will be commonly used throughout this research paper and 
are defined as follows. 
Antioxidant. Any substance that when present at low concentrations compared 
with those of an oxidizable substrate significantly delays or prevents oxidation of that 
substrate (Halliwell & Gutterridge, cited in Halliwell, 2001). 
Chocolate liquor/CocodDark Chocolate Flavonoids. Referring specifically to 
catechin, epicatechin, and procyanidins. 
Cocoa Liquor. Cocoa nib which is finely ground (Beckett, 2000). 
Cocoa Mass. Another name for cocoa liquor (Beckett, 2000). 
Cocoa Nibs. Cocoa beans with the shell removed (Beckett, 2000). 
Dark chocolate. Any chocolate that has 15 % or greater chocolate liquor. 
Flavonoids. A category of polyphenols that are considered to be very important 
because they are the most commonly occurring and widely distributed throughout the 
plant kingdom, produced as secondary plant metabolites (Bloor, 2001; Bravo, 1998). 
Ganache. Referring to the inside content of truffles. 
Methylxanthines. Referring specifically to caffeine and theobromine. 
Monomer Flavanols. Referring specifically to catechin and epicatechin. 
Polyphenols. Referring to a compound comprised of two or more aromatic rings, 
with each ring containing one or more hydroxyl groups (Lazarus et al., 2001). 
Chapter 11: Literature Review 
History of Chocolate 
Chocolate is produced from cocoa beans of the cacao tree, Theobroma cacao. 
Theobroma cacao is native to the Amazon rainforests of South and Central America and 
is believed to have naturally spread northward to Mexico and Guyana (Minifie, 1989). 
There are over twenty species of Theobroma trees, but only T. cacao is used to produce 
commercial cocoa/chocolate products. Two distinct subspecies of T. cacao are believed 
to have developed from the spread of the cacao tree, Criollo and Forastero. A third 
subspecies, Trinitario, is a hybrid of the Criollo and Forastero. 
Commercial cacao trees are grown in tropical regions 20" north and 20" south of 
the equator, where suitable growing conditions such as high average temperatures, 
humidity, and rainfall favor tree growth (Beckett, 2000). Currently, there are three major 
cocoa growing regions: West Africa, South-East Asia, and South America. 
The first known cocoa plantations were developed by the ancient Mayan culture 
in the south Yucatan of present day Mexico, around 600 AD, where cocoa beans were 
roasted and milled (Beckett, 2000). Cocoa beans were highly regarded in the Central and 
South American cultures of the Mayans, Aztecs, and Incans. Historical illustrations 
depict cups of "chocolat1"-a mixture of roasted and crushed cocoa beans, water, maize 
and spices-being consumed at wedding ceremonies and in the court of the Aztec 
emperor, Montezuma (Minifie, 1989). The chocolate drink was very fatty due to the high 
levels of cocoa butter present and had a very bitter taste. 
Christopher Columbus first introduced cocoa beans to Europe, but when the 
Spaniards conquered Mexico, Don Cortez introduced the chocolatl drink to Spain in the 
1520s (Beckett, 2000). The concoction was primarily unknown in Europe until the early 
to mid1600s, when it first came to Italy, then spread to France and England. The 
chocolate drink was very expensive; therefore, it could only be afforded by European 
royalty and aristocracy. By 1657, chocolate drinking houses were present in London. 
The development of chocolatl to chocolate as it is known today was produced by 
over 200 years of cocoa bean processing developments. The most important development 
occurred in 1828, when Van Houten developed the cocoa press (Beckett, 2000). The 
cocoa press was a machine that involved treating the cocoa beans during the roasting 
process with an alkali liquid, pressing the cocoa beans to remove about half of the fat 
content, and milling the product into a powder. 
The modern chocolate bar of today can be attributed to the development of the 
cocoa press machine. Since half of the fat from the cocoa bean was removed using this 
machine process, cocoa powder producers were left with a considerable amount of excess 
fat, called cocoa butter (Beckett, 2000). Confectioners discovered that a solid, uniform 
eating chocolate could be produced by combining milled cocoa, sugar, and cocoa butter, 
therefore, providing a market for the previously unwanted cocoa butter. 
Cacao Bean Genus and Chocolate Attributes 
Three genera of T. cacao, Criollo, Forastero, and Trinitario, produce cacao beans 
with different taste characteristics (Lass, 1999). Forastero beans are the most widely 
produced, accounting for 93.5% of world production. The Forastero beans are described 
as having a more astringent taste because they have more polyphenol tannins than the 
other cacao tree genera (Lopez, 2002). The Criollo beans have a milder, nutty flavor than 
the Forastero, and only make up 1.5% of world production (Lass, 1999). Because of their 
delicate flavor, the Criollo genus is used to make fine or premium chocolates. The 
Trinitario is a hybrid of the Criollo and Forastero; its sensory attributes are typically a 
combination of the two genera. 
Cocoa Pod Harvesting 
Chocolate production starts with the harvesting of the cacao pods. Mature pods 
from the cacao tree are harvested over a period of several months because the trees 
simultaneously bear mature pods, flowers, and growing pods (Minifie, 1989). Once the 
mature pods are removed from the cacao tree, they are taken to a fermentary where the 
cacao beans are separated from the pod and pulp by cracking the pod open with machetes 
or wooden clubs. Each pod may contain between 30-45 cocoa beans, which are hand- 
separated from the surrounding white pulp (mucilage). The cocoa beans consist of an 
outer shell or testa which surrounds two cotyledons (nibs) and a small germ (embryo) 
(Beckett, 2000). The cotyledons store the food for the developing seedling in the form of 
fat, called cocoa butter. 
Fermentation and Drying 
Cacao bean fermentation and drying are vital steps in cocoa processing that 
directly affect the flavor of the final cocoa or chocolate product (Beckett, 2000). 
Fermentation kills the live cocoa bean; it is unable to be spoiled by germination. The 
fermentation process of cocoa is technically not fermentation because microorganisms do 
not come directly in contact with the cotyledons, which is the part of the cocoa bean used 
to make chocolate (Minifie, 1989). For that reason, the fermenting process may be 
referred to as 'curing'. 
Chemically, many changes take place in the cacao pod during fermentation. 
Within the first three days of heat treatment, the temperature of the beans rises to about 
45°C (Beckett, 2000). Yeasts which are naturally present on the cocoa bean break down 
the sugars that are present in the pulp. The yeasts cause the amount of sugars present to 
decrease from 11% to 2%, thereby converting the sugars to ethanol. The formation of 
ethanol stimulates acetic acid and lactic acid bacteria to oxidize the alcohol and produce 
their respective acids, acetic acid and lactic acid. As the temperature of the beans is 
maintained between 45-50°C, due to the bacterial activity, some acetic acid is absorbed 
by the cotyledon, causing proteins and peptides to react with polyphenols to produce the 
customary "cocoa brown" color (Hoskin & Dimick, 1988). These reactions cause the 
polyphenol levels to significantly decrease during fermentation (Adamson et al., 1999). 
Other important chemical reactions occur between sucrose and proteins, which form 
cocoa flavor precursors. After the fermentation process is complete, it is necessary to dry 
the cocoa beans to a 7-8% moisture level, which helps retard mold growth (Beckett, 
2000). The heap method and the box method are two methods used to ferment the beans. 
Heap fermentation is used for small batches which can range from 25-2500 kg of 
fresh beans, combined with a small amount of attached white pulp (Beckett, 2000). The 
beans and pulp are covered with banana leaves and allowed to ferment for 5-6 days 
outside and are rotated every 2-3 days. Variations in fermentation time and heap size can 
both attribute to the final flavor and smaller heap sizes tend to produce better flavors. 
Box fermentation is used for larger batches of beans, ranging from 1-2 tons 
(Beckett, 2000). The beans are placed in large wooden boxes which have outlet draining 
slits at the base of the box, where excess water from the beans and pulp drains. Boxes can 
be as deep as 1 meter; however, more shallow boxes produce a better flavor due to 
enhanced ventilation. The beans are typically rotated from one box to another to increase 
aeration and provide a more uniform fermentation. The fermentation time period is 
between 5-8 days. Fermentation is subsequently followed by cocoa bean roasting. 
Roasting 
The roasting process is the most vital step in the development of the traditional 
cocoa flavor of chocolate. The cocoa beans are roasted in order to intensify the complex 
interaction between the flavor precursors which result in chocolate flavors (Hoskin & 
Dimick, 1988). Roasting can occur by three different methods: whole bean roasting, nib 
roasting, or liquor roasting (Beckett, 2000). The following flow diagram outlines the 
general chocolate processing procedure, demonstrating variances in the roasting 
procedure (adapted from Beckett, 2000). 
Ferrnented/Dried Clean Cocoa Beans 
I Roast I 
I 
I Winnow I 
Grind ri 
Whole Bean Roasting 
Thermal Pre-treat G
Nib Roasting Liquor Roasting 
Figure I .  Cocoa Bean Roasting Flow Diagram. 
Source: Becket, 2000 
Alkalization 
Alkalization (also referred to as Dutching) is a process that refers to the treatment 
of cocoa powder, liquor, beans, or nibs with an alkali solution, potassium or sodium 
carbonate, in order to develop a darker color of the cocoa product and adjust the taste 
(Bixler & Morgan, 1999). Alkalization results in products that tend to be less acidic, and 
products with less harsh sensory characteristics. The alkalization process is not a 
mandatory processing step, but some chocolate producers use an alkalized liquor to 
produce the final product, while others use natural, unalkalized liquor. 
During the alkalization process, many chemical reactions take place involving 
procyanidins, a group of epicatechin oligomers (Adarnson et al., 1999). The alkalization 
process is known to cause chemical alterations to the polyphenols, thereby decreasing the 
total polyphenol content of Dutched chocolate products. 
FDA Regulations on the Composition of Dark Chocolate 
Chocolate is regulated by the US FDA to ensure that consumers receive a 
standardized product and are not deceived by terminology. In the US Code of Federal 
Regulations, dark chocolate produced in the US is referred to as "sweet chocolate" and is 
described in section 163.123 of Code of Regulations, Title 2 1, Volume 2 (Food and Drug 
Administration, 2003). Sweet chocolate is defined as a solid or semi-plastic food 
prepared by mixing and grinding chocolate liquor with one or more optional nutritive 
carbohydrate sweeteners, and may contain one or more of the following: 1) cacao fat; 2) 
nutritive carbohydrate sweeteners; 3) spices, natural and artificial sweeteners, ground 
whole nut meats, dried malted cereal extract, salt, and other seasonings that do not either 
singly or in combination impart a flavor that imitates the flavor, chocolate, milk or butter; 
4) dairy ingredients such as cream, milk fat, butter, milk, concentrated milk, evaporated 
milk, sweetened condensed milk, dried milk, skim milk, concentrated skim milk, 
evaporated skim milk, sweetened condensed skim milk, nonfat dry milk, concentrated 
buttermilk, dried buttermilk, and malted milk; and 5) emulsifying agents in which the 
total weight does not exceed 1 % by weight. In addition to these requirements, the 
finished dark chocolate product must not contain less than 15% by weight of chocolate 
liquor and must contain less than 12% by weight of total milk solids as described in 4) 
dairy ingredients. 
The amount of polyphenols present in a finished dark chocolate product depend 
on the cacao bean variety, amount of chocolate liquor, amount of milk solids, alkalization 
processing, and fermentation, all of which may affect the final polyphenol content of the 
dark chocolate (Adamson et al., 1999; Natsume et al., 2000). 
Ingredients of Dark Chocolate 
Chocolate liquor. Chocolate liquor can be defined as the cocoa nibs which are 
finely ground (Apgar & Tarka, 1999). Chocolate liquor is also known as baking 
chocolate or unsweetened chocolate. All chocolate and cocoa products are produced from 
chocolate liquor. Since chocolate liquor is derived directly from the cacao pod, without 
the addition of other ingredients, it has the highest amount of polyphenols when 
compared with other chocolates with other ingredients added (Natsume et al., 2000). 
Cocoa butter. Cocoa butter is the fat component that is extracted from the cocoa 
bean cotyleydon and is used in solid chocolate products. Cocoa butter is extracted from 
either cocoa liquor or from whole cocoa beans (Kleinert, 1988). Cocoa butter is a 
triglyceride in which 95% of the fatty acids present are palmitic, stearic, and oleic acids 
(Beckett, 2000). The composition of these fatty acids is what gives chocolate its unique 
property-a small temperature range between its solid and liquid state. 
Nutritive carbohydrate sweeteners. The most common type of sweetener used to 
produce chocolate is sucrose (Kriiger, 1988). Sucrose is a disaccharide, composed of two 
chemically linked monosaccharides, glucose and fructose. Crystallized sucrose is the 
most favorable sugar used in chocolate manufacturing due to its physical properties, 
which include low moisture content (0.06%), a low percentage of invert sugar (0.04%), 
and relative sweetness rating of 1 .O. Invert sugar is typically undesirable due to its 
aqueous nature. 
The low moisture content of sucrose is necessary during storage before chocolate 
manufacturing to prevent physical, chemical, and microbiological damage (Kriiger, 
1988). Sucrose it recommended to be stored between 20 and 60% relative humidity and 
20°C to maintain a moisture content of 0.06%. Glucose and fructose are typically not 
used to manufacture chocolate because of their high moisture content. 
Other sweeteners often used in chocolate manufacturing include monosaccharide 
sugar alcohols, such as sorbitol, mannitol, and xylitol. Sugar alcohols are used in 
chocolate manufacturing because they affect the blood glucose levels less significantly 
than sucrose and therefore are desirable products for diabetics and dieters (Kriiger, 1988). 
The combination of different sugar alcohols such as maltitol and xylitol can produce a 
sweetening effect in chocolate undistinguishable from sucrose. 
Dairy ingredients. Chocolate producers may choose to incorporate milkldairy 
products into dark chocolates, in amounts less than 12% by weight (Food and Drug 
Administration, 2003). The optional dairy ingredients that may be incorporated into dark 
chocolate were previously listed in FDA Regulations on the Composition of Dark 
Chocolate (Food and Drug Administration, 2003). 
Milk products and milk solids are used to a greater extent in milk chocolate 
manufacturing as opposed to dark chocolate manufacturing (Wiirsch & Finot, 1999). The 
addition of milk products/solids to chocolate adds protein, calcium, lactose, and fats. 
Beyond its nutritive value, the addition of milk products/solids to chocolate tends to 
improve its taste and add desirable sensory descriptors to the final product. 
Emulsr~ers. Lecithin is the traditional emulsifier used in chocolate production 
(Beckett, 2000). Lecithin has the ability to blend together immiscible substances (polar 
and non-polar) that are in contact with one another. In chocolate, the role of an emulsifier 
is to blend together polar and non-polar ingredients, namely sugar and lipids (cocoa 
butter and/or milk fats). Typically, these substances would not blend together, but instead 
create an immiscible liquid. When an emulsifier is added, it coats the sugar surface with a 
polar end, and the non-polar end of the lecithin molecule will remain in the lipid portion, 
which allows the sugar to be dispersed throughout the lipid components. The FDA allows 
a maximum level of total emulsifiers to be no more than 1 % by weight (Food and Drug 
Administration, 2003). 
Optionalflavoring ingredients. Optional flavoring ingredients are defined by the 
FDA as any spice, artificial or natural flavorings, nuts, coffee, malted cereal, etc., that 
does not imitate the flavor of chocolate, milk, or butter (Food and Drug Administration, 
2003). Chocolate manufacturers can make flavored, coated, or types of chocolate 
products, providing that they adhere to the FDA regulations. 
Methylxanthines in Dark Chocolate 
Caffeine (1,3,7-trimethylxanthine) (Figure 2) and theobromine (3,7- 
dimethylxanthine) (Figure 3) are purine alkaloids naturally present in chocolate and 
belong to group of chemical compounds referred to as methylxanthines (Tarka & Hurst, 
1998). Theophylline (I ,  3-dimethylxanthine), also a methylxanthine, is only present in 
chocolate in trace amounts. 
Figure 2. Caffeine. 
CH3 
Figure 3. Theobromine. 
Theobromine is present in dark chocolate in quantities six to seven times greater 
than caffeine (Apgar & Tarka, 1999). Dark chocolate must contain at least 15% chocolate 
liquor by law, but may contain more. Therefore, the caffeine and theobromine content of 
dark chocolate can be affected by the quantity of chocolate liquor present chocolate 
product. In commercial brand chocolates, a 40 g serving size of dark chocolate contains 
on average 185 mg of theobromine and 30 mg of caffeine. Many other factors can affect 
the level of theobromine and caffeine in a finished chocolate product, including cacao 
bean variety, maturity, and fermentation conditions (Apgar & Tarka, 1999). 
Caffeine and theobromine have many physiological actions in the body, including 
central nervous system stimulation, cardiac muscle stimulation, relaxation of smooth 
muscle (especially bronchial muscle), and diuretic effects (Apgar & Tarka, 1999; Gilbert, 
2004). Each of these two methylxanthines differs in the intensity of their actions on 
different body systems. For example, caffeine has strong effects on skeletal and brain 
muscle, while theobromine, although less effective physiologically than caffeine, may 
exhibit anti-cough properties by inhibiting sensory nerve functions (Usmani et al., 2004). 
Central Nervous System and Methylxanthines 
Caffeine is a central nervous system (CNS) stimulant, whereas theobromine has 
virtually no effect on the CNS (Apgar & Tarka, 1999). Stimulatory effects of caffeine 
consumed at levels between 150-200 mg results in reduced fatigue, shortened reaction 
time, sensory stimulation, and increased motor activity. Average literature values of 
caffeine and theobromine in a 40 g serving size of dark chocolate is 28 mg and 185 mg, 
respectively. For comparison, the average cola soft drink contains about 40 mg of 
caffeine per 12 ounce serving (Spiller, 1998a). 
This topic has been studied extensively, and evidence indicates that caffeine 
produces a stimulatory effect by blocking the adenosine receptor from up-taking 
adenosine, which acts as a neuromodulator (Benowitz, 1990; Spiller, 1998b). Health 
effects associated with high doses of caffeine can include insomnia, anxiety, tremors, and 
seizures (Benowitz, 1990). 
Cardiovascular System and Methylxanthines 
Both theobromine and caffeine stimulate cardiac muscle (theobromine to a greater 
degree) by modifying the contractility of muscles in the heart and blood vessels and by 
influencing neurotransmission peripherally and centrally (Apgar & Tarka, 1999; 
Fredholm, 1984; Spiller, 1998b). The effects of methylxanthines tend to be the most 
strong in those persons who do not regularly consume caffeine or theobromine (Apgar & 
Tarka, 1999; Dews, 1982). Methylxanthine consumers tend to build a resistance to 
cardiovascular effects after a one week time period of regular consumption. 
Caffeine and theobromine stimulate cardiac muscle by increasing the rate of 
contraction, which leads to increased heart rate and cardiac output. Conversely, 
methylxanthines can also stimulate the medullary vagal nuclei, resulting in a decrease in 
heart rate. The net result indicates that there may be no overall change in the heart rate 
due to methylxanthine consumption. In a recent study conducted by Barry et al. (2005), 
no significant changes were seen in the heart rate, respiration (breathslmin), or blood 
pressure in healthy adults given a single dose of 250 mg of caffeine versus a placebo. 
The effects of methylxanthines on blood pressure are a controversial topic due to 
inconsistent results from many studies (Apgar & Tarka, 1999; Nawrot et al., 2003). Some 
studies have implicated caffeine as a cause of high blood pressure, while others have not. 
For instance, in non-habitual methylxanthine consumers, caffeine and theobromine tend 
to increase blood pressure readings after a single caffeine dose; whereas, no change in 
blood pressure occurred in habitual methylxanthine consumers. It appears that one 
mechanism of action by methylxanthines is the stimulation of the central vasomotor and 
myocardium tend to increase blood pressure, whereas central vagal stimulation and 
peripheral vasodilatation tend to decrease blood pressure (Apgar & Tarka, 1999). 
Respiratory System and Methylxanthines 
Methylxanthines are recognized for their effectiveness in stimulating respiration 
and relaxing smooth muscles of the bronchi, especially theophylline and theobromine 
(Apgar & Tarka, 1999). Theobromine has been shown to display an antitussive (anti- 
cough) action that is unique to any other methylxanthine, and the mechanism of action 
appears not to be related to bronchodilator capabilities, but to its ability to inhibit sensory 
nerve activation (Usmani et al., 2004). Theobromine has insufficient bronchodilator 
capabilities, and has been excluded from much research involving the respiratory system. 
A recent study (Usmani et al., 2004), has demonstrated suppression of capsaicin 
induced sensory nerve depolarization on the human vagus nerve by theobromine, 
therefore suggesting that theobromine plays an inhibitory role on afferent nerve 
activation. No adverse cardiovascular or central nervous system side effects were 
reported. The sensory nerve inhibition is believed to function by a peripheral mechanism. 
Renal Effects of Methylxanthines 
Methylxanthines are also associated with the renal system and diuretic effects, 
especially caffeine, since it exhibits a stronger effect on the renal system than does 
theobromine (Spiller, 1998b). The diuretic effect displayed by methylxanthines is due to 
an increased renal blood flow and glomerular filtration rate. An increased diuretic effect 
causes increased calcium loss from excretion (Massey & Whiting, 1993). Increased 
calcium excretion may be considered a potential risk factor for developing osteoporosis, a 
disease in which bones mass deteriorates, rendering bones more fragile and more likely to 
break or fracture (Bruce & Spiller, 1998). 
In a comprehensive literature review of epidemiological and experimental studies 
conducted on caffeine intake and bone loss, no consistent results have been found to 
implicate caffeine as a key factor resulting in bone fracture (Bruce & Spiller, 1998). 
However, long-term patterns of high caffeine consumption and low calcium intake in 
women appear to contribute negatively to calcium and bone metabolism and are 
correlated with a loss of bone mass and increased bone fracture. Age is also implicated in 
the caffeine consumption and calcium loss debate: younger women appear to be able to 
compensate for calcium loss due to moderate caffeine consumption, while older women 
are less able to compensate for calcium loss (Bruce & Spiller, 1998; Massey & Whiting, 
1993). No specific age is associated with calcium loss compensation, but it may be 
caused by the inability to absorb calcium due to increased age. Due to conflicting data, 
more studies need to be conducted to determine the effect of caffeine on calcium 
metabolism and osteoporosis. Persons who may be affected by osteoperosis should be 
aware of the caffeine content of dark chocolate. 
Reproduction and Caffeine 
Caffeine intake and pregnancy has been extensively studied since 1980, when the 
FDA issued a warning to pregnant women to restrict their caffeine intake after animal 
studies demonstrated that caffeine had harmful effects on reproduction (Winick, 1998). It 
should be noted that animals metabolize caffeine differently than humans, and 
conclusions from animal studies on this topic cannot be directly applied to humans. 
Caffeine consumption appears to have conflicting results related to human fertility 
and spontaneous abortion (Winick, 1998). Some studies have shown that high does of 
caffeine (greater than 300 mglday) are associated with infertility and spontaneous 
abortion. However, other studies have demonstrated that consumption of caffeine in 
doses greater than 300 mglday display no effect on fertility and spontaneous abortion. In 
an epidemiological review of caffeine consumption and fertility, Nawrot et al. (2003), 
recommends that women should reduce their caffeine level to less than 300 mglday to 
increase their fertility and to decrease the risk of spontaneous abortion. Pregnant women 
who are restricting their caffeine intake should be aware of caffeine concentrations 
present in dark chocolate. 
Free Radicals 
Free radicals are often implicated as being co-factors to the development of many 
diseases. Free radicals can damage essential molecules in the body such as proteins, fat 
and DNA, which are responsible and necessary for cellular processes (Smythies, 1998). 
Once cellular functions are incapable of working properly, stress occurs, which can 
subsequently lead to disease. 
A free radical is defined as any atom or molecule (chemical species) capable of 
independent existence that contains at least one unpaired electron (Morello, Shahidi, & 
Ho, 2002). Most biological molecules are non-radicals, containing only paired electrons. 
The formation of a free radical occurs when a non-radical species loses one electron, 
leaving one unpaired electron, which now allows the free radical the ability to gain an 
electron. When a free radical gains an electron, the free radical species is terminated, and 
ceases all free radical activity. 
Some, not all free radicals can act as oxidizing agents (Pryor, 1994). Oxidation 
refers to the transfer of electrons from one molecule to another. Oxidizing agents are 
molecules that are missing an electron and will steal an electron from a neighboring 
molecule, which is physically detrimental to the neighboring molecule (Smythies, 1998). 
Reactive oxygen species (ROS) is a term often used to describe free radicals that are 
oxidizing agents (Halliwell, 2001). ROS are derived from oxygen and non-radical 
derivatives of oxygen, such as hydrogen peroxide. For example, hydrogen peroxide is a 
cellular by-product designed to undergo degradation after it degrades fatty acids. Under 
certain conditions, the cellular hydrogen peroxide degradation can fail, leaving hydrogen 
peroxide in the cell, which can quickly lead to DIVA oxidation (Frei, 1994). 
It is important to note that not all oxidizing agents found in the body are harmful. 
In fact, many biochemical processes actually create reactive oxygen species in order to 
carry out mechanisms by which they work. For example, the immune system, specifically 
white blood cells, create reactive oxygen species, used to kill pathogenic bacteria and 
viruses (Smythies, 1998). However, dietary polyphenols have displayed strong 
antioxidant capabilities against free radicals, which may help prevent chronic diseases 
(Keeny et al., 2004; Arteel, Schroeder, & Sies, 2000). 
Oxidative Stress and Antioxidants 
ROS are believed to be a major contributor to the onset of oxidative stress 
(Halliwell, 2001), which can cause cellular damage. Oxidative stress, as defined by Sies 
(1991), is a disturbance in the prooxidant-antioxidant balance, in favor of the former, 
leading to potential damage (as cited in Halliwell, 2001). Oxidative stress can result from 
the following situations, as described by Halliwell: 
1) Diminished levels of antioxidants, due to mutations in antioxidant defense 
enzymes, toxins that deplete antioxidant defenses, or deficiencies in dietary 
antioxidants; and 
2) Increased production of reactive species, such as toxins that are themselves 
reactive species or are metabolized to generate reactive species, or an excessive 
activation of natural biological systems producing reactive species. 
The role of oxidative stress on cellular components can result in 1) adaption of the 
cell or organism by up-regulation of defense systems, which can protect against damage, 
protect against damage to some extent, or overprotect, which enables the cell to resist 
higher levels of oxidative stress; 2) tissue injury, such as protein, lipids, carbohydrates 
and DNA damage; and 3) cell death, by apoptosis or necrosis. 
An antioxidant, as defined by Halliwell and Gutterridge (as cited in Halliwell, 
2001), is any substance that when present can significantly delay or prevent oxidation of 
molecule in the human body. Typically, oxidative stress is thought to be an end result and 
not the primary cause of disease process; however, oxidative stress is believed to play an 
important role in the development of human diseases (Halliwell, 2001). 
The human body creates its own antioxidants in order to combat the free radicals 
it generates; however, dietary antioxidants also contribute to scavenging free radicals. 
The primary role of antioxidants in the body is to prevent or inhibit cellular degradation 
initiated by free radical reactions (Morello et al., 2002). 
Polyphenol Antioxidants 
Polyphenols are a class of antioxidants most universally found in the human diet 
(Scalbert et al., 2005). They are widely distributed throughout the plant kingdom and 
typical dietary sources include fruits, vegetables, tea, coffee, red wine, grains and 
chocolate. Polyphenols are defined as a compound comprised of two or more aromatic 
rings, with each ring containing of one or more hydroxyl groups (Lazarus et al., 2001). 
Polyphenol antioxidant capacity can be influenced by various factors. One important 
structural factor involves the degree of hydroxylation on the B ring (Figure 4). The more 
hydroxyl groups the polyphenol has on its B ring, the more potent the antioxidant activity 
(Bors, Michel, & Stettmaier, 200 1). 
The antioxidant activity of polyphenols involves the donation of a hydrogen atom 
and transfer metal binding. Polyphenols are noted to exhibit strong antioxidant 
effectiveness, and the aroxyl radicals created as a product of free radical termination are 
sufficiently stable to avoid chain-propagation reactions (Bors et al., 2001). 
Polyphenols have the ability to donate a hydrogen atom to the free radical. Once it 
is donated to the free radical, it becomes inactivated, preventing further reactions. When 
the polyphenol antioxidant loses its hydrogen from an attached hydroxyl group, the 
radical becomes an aroxyl radical, which is sufficiently stable enough to avoid chain- 
propagation reactions (Bors et al., 2001). 
Polyphenols also have the ability to bind to transition metals, therefore inhibiting 
oxidation of cells potentially affected by the metals (Morello et al., 2002). The binding of 
metal ions by antioxidants is very important, as transition metal ions reacting with ROS 
are implicated in many chronic diseases (Fuchs, 2001). Therefore, the incorporation of 
dark chocolate polyphenols into one's diet may be beneficial by helping to prevent free- 
radical mediated diseases. 
Flavonoid Chemistry of Dark Chocolate 
Flavonoids are a category of polyphenols that are considered to be very important 
because they are the most commonly occurring and widely distributed throughout the 
plant kingdom, produced as secondary plant metabolites (Bloor, 200 1 ; Bravo, 1998). 
Flavonoid polyphenols are recognized for their ability to affect numerous enzymatic, 
intercellular, and intracellular functions, including: immune function modulation, 
inflammatory processes, vascular reactivity, antioxidant mechanisms, cell proliferation, 
and platelet function (Middleton, Kandaswami, & Theoharides, 2000). 
Flavonoids typically exist in the diphenylpropane form (C6-C3-C6), which 
involves the linkage of two aromatic rings through three carbons, which usually form an 
oxygenated heterocycle (Figure 4) (Bravo, 1998). Flavonoids can be further categorized 
into different classes. Structurally, changes will occur in ring C, such as the presence of a 
double bond, a 3-hydroxy group, and/or a 4-0x0 group and positioning of hydroxyl and 
methoxyl groups in rings A and B (Pietta & Mauri, 2001). 
Flavanols are a sub-class of flavonoids. Flavanol monomers such as (+)-catechin 
and (-)-epicatechin (Figures 5 & 6), and their oligomers, are found in cocoa and 
chocolate products (Adamson et al., 1999). Catechin and epicatechin are classified as 
flavon-3-01 monomer units (flavanols); their oligomers are classified as procyanidins 
(Lazarus et al., 2001). Numerous procyanidins can be formed from the catechin and 
epicatechin monomers, bonded through a 4-6 linkage or 4-8 linkage (Figure 5), 
(Hammerstone, Lazarus, & Schrnitz, 2000). 
Figure 4. Flavonoid Diphenylpropane Structure. 
Figure 5. (+)-catechin. 
Figure 6. (-)-epicatechin. 
OH 
Figure 7. Procyanidin Dimer (4+8 linkage, epicatechin monomers). 
As reported by Harnmerstone et al. (2000), monomers (flavan-3-01s) contribute 
the most to the total procyanidin content in chocolate, 1.08 mglg monomers in 4.45 mglg 
total procyanidins. However, procyanidins with three or more epicatechin or catechin 
units display better antioxidant capabilities than monomers or dimers (Counet & Collin, 
2003). Dark chocolate contains a combination of monomers and procyanidins, both of 
which have shown to display effective antioxidant properties. 
Dark Chocolate & Oxidative Damage 
Oxidative damage has been considered a risk factor in the development of 
cardiovascular diseases (Rein et al., 2000a). The flavonoids present in dark chocolate 
(catechin, epicatechin, and procyanidins), are believed to provide a protective effect on 
the cardiovascular system due to their free radical scavenging capabilities and their 
ability to inhibit lipid oxidation (Wang et al., 2000). 
A study conducted by Rein et al. (2000b) investigated the epicatechin 
concentration and antioxidant capacity in human subjects at 2 and 6 hours after dark 
chocolate consumption. Each dark chocolate sample was 80 g (40 g is typical serving 
size), containing 557 mg of total procyanidins, of which137 mg were epicatechin. Within 
2 hours of the dark chocolate consumption, epicatechin plasma levels in subjects raised 
12 fold and the mean plasma antioxidant capacity significantly rose 36% greater than the 
original baseline readings. Plasma 2-thiobarbituric acid reactive substances (TBARS) are 
plasma oxidation products that were measured to determine chocolate's effect on plasma 
oxidation. After 2 hours, the TBARS were 40% lower than at baseline and 30 % lower 
after 6 hours. 
Wang et al. (2000) conducted a similar study, in which they investigated the 
antioxidant capacity and chocolate procyanidin dose concentrations. Participants were 
divided into groups that consumed 0,27, 53, or 80 g of dark chocolate in one day. Blood 
samples were collected at baseline, 2, and 6 hours from ingestion of the chocolate 
samples. The results were similar to Rein et al. (2000b), in that as epicatechin plasma 
concentrations increased, plasma antioxidant capacity increased, while plasma TBARS 
concentrations decreased. 
Other studies have also demonstrated that cocoa flavonoids delay lipid and LDL 
oxidation by increasing the oxidation lag time in vitro (Lotito & Fraga, 2000; Osakabe et 
al., 2002), and the consumption of cocoa powder and dark chocolate by human subjects 
has displayed favorable effects by moderately preventing LDL oxidation susceptibility, 
while increasing serum antioxidant capacity (Wan et al., 2001). These studies suggest 
that the consumption of cocoa and/or dark chocolate may act against plasma oxidation, 
thereby preventing the development of cardiovascular diseases. 
Dark Chocolate & Blood Pressure 
Elevated blood pressure is a risk factor for the development of cardiovascular 
diseases (Haffner & Taegtmeyer, 2003). Many recent studies on dark chocolate 
consumption have investigated the relationship between dark chocolate and blood 
pressure. 
Two studies on dark chocolate consumption and blood pressure and cholesterol 
have shown similar results. In the first study, (Grassi et al., 2005), healthy participants 
were placed in two different diet groups with the first group consuming 100 g of dark 
chocolatelday, and the second group consuming 90 g of white chocolatelday for 15 days. 
Both types of chocolate bars contained similar amounts of macronutrients, cocoa butter, 
vitamins, fiber and electrolytes. The difference between the chocolate bars was that the 
dark chocolate contained about 500 mg of total flavonoids, while the white chocolate bar 
was presumed to have 0 mg of flavonoids. Baseline and 15-day blood pressure readings 
were recorded. 
At day 15, results demonstrated that although blood pressures were within normal 
range for both chocolate groups, the dark chocolate group displayed a significant 
decrease in systolic blood pressure. 
In a similar study conducted by Taubert, Berkels, Roesen, and Klaus (2003), the 
same experimental factors were used for chocolate bar groups and doses, with the 
exception that the study was only conducted for 14 days. The study was conducted on 
elderly individuals with isolated systolic hypertension. 
At day 14, the dark chocolate group showed a decrease in systolic and diastolic 
blood pressures. Interestingly, after the discontinuation of the 100 g of dark chocolate per 
day, blood pressure levels returned to the pre-intervention levels within two days. 
Dark Chocolate and Endothelial Cell Function 
Growing evidence recognizes that vascular endothelium cell dysfunction may be a 
factor in the clinical expression of cardiovascular disease (Engler et al., 2004; Vita & 
Keaney, 2002). Endothelial cells are responsible for maintaining a level of homeostasis in 
blood vessel wall and lumen by producing nitric oxide, which acts as a vasodilator, 
prevents platelet adhesion and aggregation, and inhibits vascular smooth muscle cell 
proliferation. Nitric oxide has also shown to exhibit anti-inflammatory, anti- 
atherosclerotic, and vasodilatory actions, all of which aid in the prevention of heart 
diseases (Sies, Schewe, Heiss, & Kelm, 2005). 
Endothelial cell dysfunction causes lower levels of nitric oxide to be produced, 
resulting in the cells to adapt a phenotype that facilitates inflammation, thrombosis, 
vasoconstriction, and atherosclerotic lesion (Levine, Keaney, & Vita, 1995). The new 
endothelial cell phenotype is associated with cardiovascular risk factors such as high 
cholesterol levels, hypertension, and type I1 diabetes (Vita & Keaney, 2002). 
Flavanols and procyanidins in dark chocolate may improve endothelial cell 
function in human subjects (Engler et al., 2004). In a study recently conducted by Engler 
et al. (2004), human subjects who consumed 46 g of dark chocolate ( ~ o v e '  Dark)/day 
(21 3 mg total procyanidins, 46 mg epicatechin) demonstrated a significant increase in 
endothelium-dependant flow-mediated dilation and increased epicatechin plasma 
concentrations as opposed to the non-chocolate eating group. Increased flow-mediated 
dilation is associated with increased plasma epicatechin concentrations. Therefore, 
elevated epicatechin levels from dark chocolate consumption may be responsible for the 
increased endothelium derived vasodilatation. However, it should be noted that it is 
uncertain how flavanols and procyanidins interact with biological systems in the body to 
produce these results; possible mechanisms are being investigated. 
Dark Chocolate and Platelet Function 
Platelet aggregation and overall increased platelet activity are known risk factors 
in the development of many coronary artery diseases (Awtry & Loscalzo, 2000). Many 
studies have shown flavonoids to display platelet anti-aggregation properties in vivo in 
animal and human trials (Demrow, Slane, & Folts, 1995; Freedman et al., 2001). 
In a study conducted by Rein et al. (2000a), groups consuming cocoa flavonoids 
have displayed acute inhibition of epinephrine-induced platelet activation in vitro. In a 
similar study, Rein et al. (2000~)  replicated the inhibition of platelet activation in humans 
who consumed 897 mg of total epicatechin and procyanidins from a procyanidin- 
enriched cocoa powder. 
A study conducted by Innes, Kennedy, McLaren, Bancroft, & Belch, (2003) 
demonstrated similar results in that they noted an inhibition of collagen-induced platelet 
aggregation in platelet-rich plasma in those participants consuming dark chocolate. White 
chocolate and milk chocolate displayed no significant effect on platelets. Therefore, these 
studies all demonstrate that the consumption of cocoa andlor dark chocolate helps to 
reduce platelet aggregation, thereby reducing the risk of developing cardiovascular 
disease. 
Dark Chocolate and Insulin Sensitivity 
Resistance from insulin receptors to uptake insulin cause excess blood glucose 
levels; insulin resistance is a known contributing factor for the development of type I1 
diabetes (Haffner & Taegtmeyer, 2003). While the role of insulin sensitivity as an 
independent risk factor for the development of cardiovascular diseases is still under 
debate, a study by Balletshofer et al. (2000) has demonstrated that insulin sensitivity may 
act as an independent risk factor. 
The effects of dark chocolate on insulin sensitivity were studied by Grassi et al. 
(2005). Participants in the cross-over study were placed in two different diet groups, with 
the first group having consumed 100 g of dark chocolatelday, while the second group 
consumed 90 g of white chocolatelday for 15 days. The only difference between the 
chocolate bars was that the dark chocolate contained about 500 mg of total flavonoids, 
while the white chocolate bar was presumed to have 0 mg of flavonoids. At the end of the 
15 day trial, oral-glucose-tolerance tests were administered to calculate the homeostasis 
model assessment of insulin resistance (HOMA-IR) and the quantitative insulin 
sensitivity check (QUICKI), which are indicators of insulin resistance and insulin 
sensitivity, respectively. Blood pressures of each participant were measured daily. 
Results indicated that the dark chocolate consumption group had decreased 
fasting insulin and glucose concentrations, in addition to decreased oral testing insulin 
and glucose values. The dark chocolate group displayed statistically lower HOMA-IR 
and statistically greater QUICKI. Blood pressure results indicated that the dark chocolate 
consumption group displayed a statistically significant decrease in systolic blood pressure 
after 15 days as opposed to the white chocolate group. No significant differences were 
seen in the diastolic blood pressure values. 
This lower insulin resistance and increased insulin sensitivity displayed are 
hypothesized by Grassi et al. (2005) to be caused by dark chocolate flavonoids. Although 
the experiment did not test for nitric oxide concentrations, it can be hypothesized the 
insulin sensitivity displayed by dark chocolate consumption may have been due to a 
decrease in the group's systolic blood pressure, since elevated nitric oxide uptake by 
endothelial cells is known to decrease blood pressure (Vita & Keaney, 2002). However, 
flavanol consumption is also attributed to other cellular process which can affect insulin 
sensitivity (Grassi et al., 2005). Although no mechanism is yet clear, compounds present 
in dark chocolate appear to lower blood pressure and insulin resistance. By lowering 
blood pressure and insulin resistance, dark chocolate consumption may help prevent the 
onset of cardiovascular diseases and type I1 diabetes. 
Dark Chocolate, Oxidative Stress, Inflammation, & Cancer 
Oxidative stress and inflammation may be factors which can aid in the 
development of cancers by causing direct damage to genomic DNA, alter intracellular 
signaling, causing abnormal cell growth, and promoting damaged cells to undergo 
promotion and progression of cancerous cells (Surh, Kundu, Na, & Lee, 2005). Cells are 
equipped with certain mechanisms of defense against oxidative stress, protecting 
themselves from reactive oxygen species (ROS) free radicals. ROS and other free radical 
species are believed to be a major contributor to the onset of oxidative stress, and thereby 
cause cellular damage (Halliwell, 2001), which can subsequently lead to carcinogenesis 
(Surh et a]., 2005). 
The effects of ROS and other radicals, such as peroxynitrite, have been studied 
due to their ability to induce oxidative stress that may be caused by inflammation (Arteel 
et al., 2000). A study by Arteel et al. (2000) has shown that cocoa flavonoids such as 
epicatechin and a tetramer of epicatechin, have inhibited oxidative reactions involving 
peroxynitrite in vitro. The tetramer displayed a more potent ability to prevent oxidative 
damage than did epicatechin. This study demonstrates the potential chemo-preventive 
benefits from chocolate flavonoids. 
Dark Chocolate, Angiogenesis, and Cancer 
Angiogenesis is the formation of new capillaries from an existing blood vessel 
(Harper & Moses, 2006); the process of which is always implicated in the development 
of cancer because new capillaries are formed with tumor growth in order to supply 
nutrients and remove metabolites (Dhanabal, Jeffers, & Larochelle, 2005). By preventing 
or stopping the ability of new capillaries to grow, the ability for tumors to develop and 
grow would also be impaired. 
Keeny et al. (2004) has recently investigated the effects of cocoa flavonoids on 
the proliferation of human dermal microvascular endothelial cells (HDMECs) following 
angiogenic stimulation. This study showed that pentameric and octameric procyanidins 
inhibited induced HDMEC proliferation. Furthermore, the pentameric procyanidin 
fraction was shown to modulate the activity of signaling enzymes in angiogenic 
signaling, regulating their expression and down-regulating their receptors. 
This study, although in vitro, implies that cocoa procyanidins may have a large 
impact on factors related to tumor growth. Keeny et al. (2004) noted that the 
concentrations of procyanidins used in their study most likely exceed the level obtainable 
in vivo. However, their findings on angiogenesis regulation warrant further studies 
involving cocoa procyanidins and cellular signaling. 
Dark Chocolate Flavonoids and Inhibition of Human Colon Cancer Cell Growth 
The effects of cocoa powder and flavanol-rich extracts were investigated on the 
growth of Caco-2 cell lines, a line of human colonic cancer cells in a study conducted by 
Carndsecchi et al. (2002). Results indicated that the cocoa flavanol extracts inhibited cell 
proliferation in a dose-dependant manner. Flavonoids extracted from cocoa powder with 
a concentration of 14 1.2 mglg demonstrated the least effective cancer cell inhibition. 
However, extractions containing 5 10.5 mglg of crude procyanidin extract and 940.6 mglg 
of procyanidin-enriched extract demonstrated a 25% and 75% growth inhibition, 
respectively. Non-apoptosis cell death was also observed from the procyanidin-enriched 
extract. The authors hypothesize that the observed decrease of two key enzymes in the 
polyamine biosynthesis might be the major target of the anti-proliferative effects of cocoa 
flavonoids. 
These results indicate that cocoa flavanol extracts in high concentrations have 
anti-proliferation capabilities in vitro. Although flavanol concentrations used in this study 
are unattainable from cocoalchocolate consumption, other types of flavanol treatments 
may be created to help prevent human colon cancer proliferation. 
Dark Chocolate Flavanol and, Mammary and Pancreatic Cancers 
In a study conducted by Yamagishi et al. (2002a), the effects of cacao liquor 
procyanidins were investigated in vitro and in vivo on induced mutagenesis in female 
Sprague-Dawley rats. In vitro, the cacao liquor procyanidins inhibited induced 
mutagenesis in a non-dose dependent manner (100,200, and 400 pglplate), warranting 
further in vivo testing on pancreatic and mammary cancers in rats. 
In vivo, induced carcinogenesis of the pancreas and mammary glands was 
performed on the female rats. Cacao procyanidins were incorporated into the basal diet of 
the rats at doses of 0.025% and 0.25%. Results indicated that the incidences, 
multiplicities, and volume of mammary tumors in the 0.25% cacao liquor procyanidins 
group was less than the control group, but with no statistical significance (p < 0.05). The 
incidences of pancreatic tumors decreased in a dose dependent manner in rats fed cacao 
liquor procyanidins (0.25% < 0.025%). These results indicate that cacao liquor 
procyanidins may help to inhibit pancreatic carcinogenesis when ingested in amounts of 
0.25% and 0.025% of the basal diet. 
Dark Chocolate Flavonoids and Lung Cancer 
In a second study, Yamagishi et al. (2002b) investigated the relationship between 
multi-organ induced carcinogenesis and cacao liquor procyanidins on male F344 rats. 
Cancerous cells were found in the pituitary gland, zymbal gland, forestomach, kidney, 
urinary bladder, testis, small intestine, colon, thyroid gland, and lung after induced 
carcinogenesis. One week after initiation, the rats were fed cacao liquor procyanidins at 
doses of 0.025% and 0.25% of the basal diet. Results indicated that the survival rate of 
the 0.25% cacao liquor procyanidin group was significantly greater. A statistically 
significant reduction (p < 0.05) in the incidence and multiplicity of lung carcinomas was 
observed in the 0.25% cacao liquor procyanidin group as compared to the control group. 
A dose-dependent relationship was associated with a decrease in quantitative values of 
lung cancer. IVo significant reductions of the other types of cancers were observed. 
This study confirms the cacao liquor procyanidin dose-dependent results of the 
previous study (Yamagishi et al., 2002a). In addition to preventing pancreatic cancer 
proliferation, cacao liquor procyanidins also help to prevent lung cancer instance and 
multiplicity. Furthermore, no adverse side effects were observed in any of the major 
organs studied, implying that cacao liquor procyanidins are safe. 
Conclusion 
The experiments reviewed use dark chocolate/cocoa~chocolate liquor flavonoids 
as potential cardio and chemo preventative compounds. The studies have demonstrated 
that flavanols and procyanidins originating from the T. cacao tree and related chocolate 
products provide numerous health benefits both in vitro and in vivo. 
In addition to dark chocolate's polyphenol content, methylxanthines are also 
compounds of interest because of their prevalence in chocolate and their related central 
nervous system stimulation, cardiac muscle stimulation, relaxation of smooth muscle, and 
diuretic effects. 
These studies offer sufficient evidence to conclude that flavonoids and 
methylxanthines from cocoa and/or dark chocolate may have health benefits directly 
related to their consumption; therefore, the above presented literature review validates the 
basis of this experiment to investigate Legacy Chocolates and commercially available 
dark chocolates for flavanols and methylxanthines. 
Chapter 111: Methodology 
Flavanols such as catechin and epicatechin, and methylxanthines such as caffeine 
and theobromine are unique because both categories of compounds have similar UV-VIS 
spectra; therefore, they are able to be simultaneously extracted and analyzed via high 
performance liquid chromatography (HPLC). HPLC is the method of choice for 
flavonoid analysis because most instruments offer multi-wavelength capabilities and the 
ability to record multiple spectra (Bloor, 2001). 
Reversed-phase gradient HPLC was used to quantify levels of catechin, 
epicatechin, caffeine, and theobromine in four commercial dark chocolates and chocolate 
samples obtained from Legacy Chocolates with weight percentages of chocolate liquor 
ranging from 4 1 % to 100%. 
Fresh chocolate samples were analyzed within one week of being acquired. The 
chocolate samples were refrigerated at 3 "C. 
Subject Selection and Description 
Raw chocolate samples used to make medallions and truffle shells were obtained 
from Legacy Chocolates of Menomonie, Wisconsin. The weight percentages of chocolate 
liquor in the finished products, alkali processing infomiation, and Theobroma cacao 
genera from which the chocolate originated from are shown in Table I (M. Roberts, 
personal communication, March 30, 2006). 
Table 1 
Legacy Chocolate Variety Corresponding to Percent Chocolate Liquor, Alkali 
Processing, and Tree Genus 
Legacy chocolate Percent chocolate Alkali processed T. cacao genus 
variety liquor (96) 















Criollo & Forastero 
Brands of commercial dark chocolates obtained from local grocery stores 
included: Ghirardelli 60% cacao, Hershey's@ Dark, ~ o v e  Dark, and Lindt 70% cocoa. 
The weight percentages of chocolate liquor in the finished products and alkali processing 
information are shown in Table 2. Theobroma cacao genera from which the commercial 
dark chocolates originated were unavailable from Ghirardelli, Hershey's@, ~ o v e @ ,  and 
Lindt. 
Table 2 
Commercial Chocolate Variety Corresponding to Percent Chocolate Liquor, Alkali 
Processing, and Tree Genus 
Commercial Percent chocolate Alkali processed T. cacao genus 
chocolate variety liquor (%) 
Dovew Darka 40.0-50.0 Yes Unknown 
~ e r s h e ~ ' s @ D a r k ~  45.0 Yes Unknown 
Ghirardelli 60% 60.0 No Unknown 
cacaoC 
Lindt 70% cocoad 70.0 No Unknown 
a (L. Lisa, personal communication, May 26,2006). 
(R. Green, personal communication, June 1,2006). 
(S. Ortiz, personal communication, May 24,2006). 
(Lindt, 2006). 
Standard Solutions Preparation 
The polyphenolic compounds, (+)-catechin and (-)-epicatechin, and 
methylxanthine compounds, caffeine and theobromine, were used to prepare stock 
solutions. Catechin, caffeine, and theobromine standards were obtained from Sigma (St. 
Louis, MO). The epicatechin standard was obtained from Aldrich (Milwaukee, WI). 
Stock solutions of caffeine (1000 mg/L) and theobromine (800 mg/L) were prepared by 
dissolving the compounds in approximately 700 mL of a 50:50 (vlv) methanol-~illi-Q@ 
water solution heated to 60°C. After the caffeine and theobromine were dissolved, they 
were allowed to cool to room temperature before being diluted to volume. Stock solutions 
of catechin and epicatechin (1 000 mg/L) were prepared by dissolving the compounds in 
methanol. Standard mixture solutions of catechin, epicatechin, caffeine and theobromine 
were prepared by volumetric transfer of the stock solutions into 100-mL volumetric 
flasks and diluted to volume with methanol. The concentrations of the stock solutions are 
listed in Table 3. 
Table 3 
Standard Mixture Solutions Concentrations 
Standard mixtures Concentration (mg/L) 
Catechin Epicatechin Caffeine Theobromine 
Standard mix 1 10 10 25 160 
Standard mix 2 20 2 0 50 240 
Standard mix 3 30 3 0 7 5 320 
Standard mix 4 40 40 100 400 
Standard mix 5 50 50 125 480 
Polyphenol and Methlyxanthine Extraction 
Chocolate samples were stored in a refrigerator until analyzed. Each sample was 
finely ground using an Osterizer blender. Approximately two grams of each ground 
sample was weighed on an analytical balance and was transferred to an Erlenmeyer flask. 
To each sample, 25 mL of Milli-Q@ water warmed to 95" C was added. The samples were 
stirred on a stir plate at a medium setting for 40 minutes. All samples were then 
transferred via a funnel into 50-mL volumetric flasks and allowed to cool to room 
temperature; the stir bar, Erlenmeyer flask, and funnel were rinsed with Milli-Q@ water to 
ensure quantitative transfer. Once room temperature was reached, each flask was diluted 
to volume with Milli-Q' water. Next, each sample was filtered by a funnel lined with 
~ha tman '  # 1 (1 10 mm diameter) filter paper to separate the water-soluble liquid 
component from lipids and other insoluble components. Before transferring to 
autosampler vials, each sample was filtered with a new ~ h a t m a n '  0.45 pm 
polypropylene membrane filter. 
Instrumentation 
A Waters high performance liquid chromatography (HPLC) system with 
Millennium' software was used to identify and quantify (+)-catechin, (-)-epicatechin, 
caffeine and theobromine in the chocolate samples from a modified HPLC method 
(Yang, 1988). The column used in the analysis was a Waters Radial CompressionTM 10 
cm x 8 mm ID Novapak C18 column with a NovaPak GaurdPak in an RCM-100 radial 
compression module. Gradient conditions are described in Table 4. Solvent A consisted 
of Milli-Q' waterlglacial acetic acid 99.5:0.5 (vlv) and solvent B consisted of Milli-Q' 
water/acetonitrile/glacial acetic acid 59.5:40.0:0.5 (vlv). The flow rate was set at 2.0 
mL1minute and the run time was 35 minutes. The injection volume for each sample was 
25 pL. The HPLC hardware used included a Waters 717 Plus autosampler, Waters 1525 
Binary HPLC Pump, and a Waters Photodiode Array Detector. The system was 
controlled with a PC using a ~ i n d o w s ' ~ ~  operating system and Waters Millennium' 
4.0 software. 
Table 4 
Mobile Phase Gradient Separation Conditions 
Time (min) Flow (mL/min) %A %B Curve 
The UV-Vis spectra of the analytes were measured with an ~ l i ~ e n t '  UV-Vis 
spectrophotometer with UV-Vis Chem Station software. At concentrations of 10 mg/L, 
the UV absorption maxima of catechin and epicatechin were determined to be 280 nm; 
caffeine and theobromine were 272 nm (Figures 8,9,  10, and 11, respectively). 
Therefore, chromatograms were collected using analytical wavelengths of 278 and 290 
nrn; these wavelengths are close to the b, for the analytes being investigated. An 
example chromatogram for a standard mixture containing catechin (20 mg/L), 
epicatechin (20 mg/L), caffeine (50 mg/L), and theobromine (240 mg/L) is displayed in 
Figure 12; an example of a chromatogram for a Legacy Chocolates product, Legacy 
Chocolate 73.5%, is displayed in Figure 13. 
Figure 8. Catechin UV-spectra. 
Figure 9. Epicatechin UV-spectra. 
Figure 10. Caffeine UV-spectra. 
Theobromine 10 mgll In methanol 
Figure 11. Theobromine UV-spectra. 
Figure 12. Chromatogram of Standard Mixture. 
1. theobromine (240 mg/L); 2. catechin (20 mg/L); 3.  caffeine (50 mg/L); and 
4. epicatechin (20 mg/L) 
O W  200 4~ aoo sw r o w  i z x  i r m  i b a .  .RIN 2000 2203 24 to :SCO 20 w 35w 321.0 - 4 x  
M lir e, 
Figure 13. Legacy Chocolates 73.5% Chromatogram. 
1. theobromine; 2. catechin; 3. caffeine; and 4. epicatechin 
Data Analysis 
Statistical differences between the mean concentrations (mgl40g) of catechin, 
epicatechin, caffeine, and theobromine for each chocolate variety were examined by one- 
way ANOVA with post-hoc testing. The statistical analysis was performed using the 
computer statistical package SPSS version 12.0. Differences between mean 
concentrations were assessed by a Student-Newman-Keuls t-test. P<0.05 was considered 
statistically significant. 
Limitations of the Study 
The extraction process of the analytes is a limitation of the study. The 
quantification of flavanols and methylxanthines by HPLC is dependant on the proficiency 
of the extraction process. The HPLC instrumentation is another limitation. Flavanol and 
methylxanthine concentrations are based on the HPLC's capability to quantify those 
components. 
Chapter IV: Results and Discussion 
The HPLC method used was developed to allow detection of flavanols (catechin 
and epicatechin) and methylxanthines (caffeine and theobromine) simultaneously from 
solid chocolate samples. The concentration of flavanols and methylxanthines was 
determined in the four chocolate medallion products manufactured by Legacy Chocolates 
and in the chocolate liquor used in their preparation. Other commercial brand dark 
chocolate manufactured by ~ o v e @ ,  Ghirardelli, ~ e r s h e ~ @ ,  and Lindt were also analyzed. 
Using the average retention times obtained by standards, peaks were identified in 
chocolate samples (Table 5) so that tentative peak identities could be verified by 
comparing their 2781290 nm peak area ratios to those of standards. Each component 
analyzed (catechin, epicatechin, caffeine, and theobromine) had similar peak area ratios 
at 278 and 290 nm as compared to each standard. The chocolate samples had similar peak 
areas at 278 nm and 290 nm (Table 6), which confirms that the analyte of interest was 
present in each dark chocolate sample. Concentrations (mg1L) of catechin, epicatechin, 
caffeine, and theobromine displayed in Table 6 were determined from individual 
compound standard curves (Appendixes A-D). 
Table 5 
Retention Times and Peak Area ~ a t i o s ~  
Compound Retention time (min) Peak area ratios (2781290) 
Theobromine 13.97 0.07 2.77 0.03 
Catechin 18.52 0.07 2.94 0.02 
Caffeine 18.99 * 0.06 3.28 0.00 
Epicatechin 21.02 0.06 3.32 * 0.02 
Mean of three trials * standard deviation 

Calculation of Catechin, Epicatechin, Cafleine, and Theobromine 
The concentrations of each compound per 40 g serving size were calculated using 
the following equation: 
Concentration (mg/L) * 0.05 L * 112.00 g* 40 glserving size = mg140 g serving size 
The average concentration and standard deviation of each compound (mg140 g 
serving size) is displayed in Table 7 for each dark chocolate sampled. The compound 
concentrations were given in mg140 g serving size for ease of comparison with current 
human studies that typically denotes the catechidepicatechin or total polyphenols in 
milligrams per serving size. Methlyxanthine values (mgl40 g serving size) from dark 
chocolates in this study agreed with literature values published by Apgar and Tarka 
(1999). Apgar and Tarka reported "dark" or "sweet" chocolate as containing 185 mg of 
theobromine per 40 g serving size and 28 mg of caffeine per 40 g serving size. These 
values are similar to values obtained from dark chocolates tested in this study, such as 
~ o v e @  Dark 40-50% (177 mgl40 g theobromine and 24.8 mgl 40 g caffeine) and 
~ e r s h e ~ ' s @  Dark 45% (1 85 mgl40 g theobromine and 1 7.8 mg140 g caffeine) (Table 7). 
Therefore, comparable values to Apgar and Tarka are found in the current study. 
The average concentration and standard deviation of each compound (mglg) are 
displayed in Table 8. Flavanol monomer concentrations in chocolate samples labeled 
"dark chocolate" and "high liquor chocolate" as reported by Adamson et al. (1999) were 
0.8 mglg and 4.0 mglg, respectively. In comparison, all chocolates sampled in this study 
(Table 8) were within the range of flavanol monomers (mglg) published by Adamson et 
a1 (1 999). For example, ~ e r s h e ~ ' s @  Dark 45% contained 0.52 mglg of total monomer 
flavanols and Lindt 70% contained 1.08 mglg of total monomer flavanols (Table 8). 
Table 7 
Methylxanthine and Polyphenol Concentrations per 40 g serving sizet 
Chocolate sample Concentration (mg)/40 gram serving size 
Catechin Epicatechin Total flavanol Caffeine Theobromine Total methyl- 
monomers xanthines 
~ o v e @  Dark 40-50%" 6.3 i 0.3 6.56* 1.1 12.9* 1.4 24.8 i 0.3 177*3 202 * 3 
Legacy 4 1 %" 2.5 i 0.4 6.5 i 1.5 8.91 * 1.9 23.4 * 0.9 65 * 2 88 * 3 
~ e r s h e ~ ' s @  Dark 45%a 8.7 * 0.9 12.0 i 1.7 20.7 i 2.6 17.8 * 0.6 185 i 4 203 * 5 
Legacy 58.5%" 4.3 * 0.3 18.4 i 2.6 22.7 i 2.9 40.7 * 1.4 1 6 0 i  6 201 * 8 
Legacy 60%" 8.9 * 0.9 29.2 2.2 38.1 * 3.1 25.2 * 0.2 3 0 2 i  5 327 * 5 
Ghirardelli 60%a 7.9 i 0.7 27.2 i 4.6 35.1 * 5.3 34.4 * 0.9 206 * 4 240 * 5 
Lindt 70%" 10.4 * 2.1 32.7 * 2.2 43.1 * 4.3 35.5 * 0.8 284 * 10 320* 11 
Legacy 73.5%" 8.7 * 1.6 24.7 * 6.3 33.4 * 7.9 49.9 * 0.8 207 * 1 257 * 2 
Chocolate liquor 18 .6 i  1.2 70.0 * 4.9 88.6 * 6.1 59.4 * 1.6 414 * 7 473 * 8 
(1 OO%)a 
mean of three trials * standard deviation 
a percentage of chocolate liquor 
1 Methylxanthine and Polyphenol Concentrations (mg/a) of Dark chocolatest 
1 Chocolate sample Concentration (mg/g) 
Catechin Epicatechin Total Flavanols Caffeine Theobromine Total Methyl- 
xanthines 
~ o v e @  Dark 0.16 * 0.01 0.16 * 0.03 0.32 * 0.04 0.62 * 0.01 4.43 * 0.08 5.05 * 0.09 
40-50%a 
Legacy 4 1 %a 0.06 * 0.01 0.16 * 0.04 0.22 * 0.05 0.59 * 0.02 1.62 * 0.06 2.21 * 0.08 
~ e r s h e ~ ' s @  Dark 0.22 * 0.02 0.30 * 0.04 0.52 * 0.06 0.45 * 0.01 4.63 * 0.1 1 5.08 *0.12 
45%a 
Legacy 58.5%a 0.1 1 5 0.01 0.46 * 0.07 0.57 * 0.08 1.02 h 0.04 4.00 * 0.16 5.02 * 0.20 
Legacy 60%a 0.22 * 0.02 0.73 * 0.06 0.95 * 0.08 0.63 h 0.01 7.55 * 0.12 8.18 * 0.13 
Ghirardelli 60%a 0.20 * 0.02 0.68 * 0.12 0.88 * 0.14 0.86 * 0.02 5.15 * 0.10 6.01 * 0.12 
Lindt 70%a 0.26 * 0.05 0.82 * 0.06 1.08 * 0.1 1 0.89 * 0.02 7.1 0 0.26 7.99 * 0.28 
Legacy 73. 5%a 0.22 h 0.04 0.62 0.16 0.84 * 0.20 1.25 * 0.02 5.18* 0.03 6.43 * 0.05 
Chocolate liquor 0.47 * 0.03 1.75 * 0.12 2.22 4~ 0.15 1.49 * 0.04 10.35 * 0.17 1 1.8 * 0.21 
(1 OO%)a 
a percentage of chocolate liquor 
Legacy Chocolates Medallions and Truffle Shells 
The mass of individual medallions and truffle shells (with ganache removed) was 
used to calculate the amount of catechin, epicatechin, caffeine, and theobromine per 
serving size. Results (mgl Legacy Chocolates serving size) are shown in Table 9 to 
demonstrate the amount of flavanols and methylxanthines per truffle or 2 medallions, as 
sold by Legacy Chocolates. 
The chocolate liquor used to produce the truffles and medallions came from the 
same chocolate source (M. Roberts, personal communication, March 30,2006); 
therefore, it was expected that as the percentage of chocolate liquor increased, the 
concentration of flavanols and methylxanthines should have also increased. Table 9 
demonstrates that the greater the percentage of chocolate liquor added to the finished 
product, the greater the flavanol and methylxanthine concentration. For example, 
comparing a serving size of Legacy 41% and 73.5% medallions, Legacy 41% had 4.4 
mglserving size of epicatechin and 16.0 mglserving size of caffeine, while legacy 73.5% 
had 16.9 mglserving size of epicatechin and 34.0 rnglserving size of caffeine (Table 9). 
The medallions provided more flavanols and methylxanthines because the serving size 
for medallions is larger than the truffles. For example, Legacy's 73.5% medallion had a 
greater epicatechin content (1 6.9 mgl27.18 g serving size) (Table 9) as compared to 
Legacy's 73.5 % truffle shell (4.0 mgl6.38 g serving size) (Table 9). These differences 
can be attributed to the weight difference between the two samples. Also, since only the 
truffle shell was analyzed, and not the ganache, which is typically prepared with dark 
chocolate, it is anticipated that the flavanol and methylxanthine content of the entire 
truffle would increase. 
Table 9 
Flavanol and Methylxanthine Concentration per Legacy Chocolates Medallion and 
Truffle Shell Serving sizest 
Legacy Serving Size Concentration (mglserving size) 
Chocolate 
Type Theobromine Caffeine Catechin Epicatechin 
41%" 2b 44.0 * 1.6 16.0*0.5 1.6*0.3 4.4 * 1.1 
medallion 
58.5%" 2b 109* 4 27.7*1.1 3.01t0.3 12.5 * 1.9 
medallion 
73.5%a 2b 141 * 1 34.0i0 .5  6.0*1.1 16.9 * 4.4 
medallion 
'mean of three trials + standard deviation 
a Percentage of chocolate liquor. 
Medallions (27.18 g + 0.98). 
' Truffle shell. 
Truffle shell only, no ganache (6.38 g + 0.69). 
Means Comparison and Statistical Analysis 
The Student-Newman-Keuls t-test (p < 0.05) was used to determine statistical 
differences between the means of the analyte concentrations (mg/40g). 
Legacy Chocolatesflavanols. Results for statistical differences between Legacy 
chocolate varieties for catechin and epicatechin concentrations are shown in Figures 14 
and 15, respectively. The total amounts of monomer flavanols for all chocolate varieties 
are shown in Figure 16. In general, for Legacy Chocolates the greater the percentage of 
chocolate liquor that was added to the finished product, the greater the flavanol 
antioxidants present. For example, Legacy 60% chocolate had 8.90 mgl40 g catechin, 
while Legacy 40% had only 2.46 mgl40 g catchin. And, as anticipated, Legacy's 
chocolate liquor (100%) had significantly greater concentrations of catechin (1 8.6 mgl40 
g) (Figure 14) and epicatechin (70.0 mgl40 g) (Figure 15) than any other chocolate type 
attributed to the chocolate liquor as the source of dark chocolate polyphenols. Therefore, 
chocolate liquor at 100% was demonstrated to be the greatest source of total monomer 
flavanols (88.6 mgl40 g) (Figure 16) as compared to other lower chocolate liquor 
containing samples. A recent study demonstrated that the consumption of 46 mg of 
epicatechin and 2 13 mg of procyanidins from dark chocolate over a two week period 
resulted in a significant increase in endothelium-dependant flow-mediated dilation and 
increased epicatechin concentrations, both of which help prevent the development of 
cardiovascular diseases (Engler et al., 2004). This current finding would indicate that at 
these levels of epicatechin, Legacy's chocolate liquor (100%) would be an ideal 
chocolate product to consume in order to attain a substantial content of dietary 
flavonoids; however, chocolate liquor is not commonly consumed due to its bitter 
sensory attributes. However, the consumption of Legacy dark chocolates having a large 
total flavanol concentration, such as with Legacy 60% (38.1 mgl40 g) and Legacy 73.5% 
(33.4 mgl40 g) (Figure 16) may also increase endothelium-dependant flow-mediated 
dilation and epicatechin plasma concentrations. 
Interestingly, the Legacy chocolate prepared from 60% chocolate liquor had a 
significantly greater concentration of epicatechin (29.2 mgl40 g) as compared to Legacy 
58.5% (1 8.4 mg/40 g) (Figure 15). Since the percentages of chocolate liquor added to 
Legacy 58.5% and Legacy 60% dark chocolate were similar, it would be expected that 
the flavanol content would also be similar. Although there were no significant differences 
between catechin and epicatechin concentrations for Legacy 60% and Legacy 73.5%, the 
total monomer flavanols was greater in Legacy 60% (38.1 mg/40 g) as compared to 
Legacy 73.5% (33.4 mg/40 g) (Figure 16). It was expected that Legacy 73.5% dark 
chocolate would have a greater concentration of total monomer flavanols than Legacy 
60% because Legacy 73.5% has a greater concentration of chocolate liquor added to the 
finished product. Since all of Legacy's chocolates are processed with alkali, it is unlikely 
that alkalization attributed to the difference in flavanols between the three chocolate 
types. A possible explanation for this difference may be explained by the cacao tree 
genera: Legacy 60% is made from the Forastero genus, while the 58.5% and 73.5% is 
made from the Criollo genus. The Forastero genus has been cited in literature to contain 
more polyphenols than the Criollo genus (Lopez, 2002). 
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Figure 14. Mean Catechin Concentrations (mgl40g) for Legacy chocolates.' 
t Percentage of chocolate liquor. 
Values followed by different lowercase letters are significantly different (p i 0.05). 
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Figure 15. Mean Epicatechin Concentrations (mgl40g) for Legacy ~hocolates.' 
t Percentage of chocolate liquor. 
' Values followed by different lowercase letters are significantly different (p < 0.05). 
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Figure 16. Mean Monomer Flavanols (mgl40 g, catechin and epicatechin) for all 
Chocolate Types. 
t Percentage of chocolate liquor. 
Flavanols, Legacy Chocolates, & commercial dark chocolates. Figures 17 and 18 
demonstrate the results of catechin and epicatechin concentrations among all chocolate 
varieties. The percentage of chocolate liquor added to the finished commercial dark 
chocolate products (eg., Hershey's@, Lindt) is shown in Table 2 in order for a direct 
comparison of commercial brand chocolates to Legacy Chocolates based on the 
percentage of chocolate liquor added. Commercial chocolates and those Legacy 
chocolates having similar percentages of chocolate liquor may be expected to contain 
similar concentrations of flavanols. 
The chocolate samples containing the largest levels of catechin (excluding 
chocolate liquor) were Lindt 70% (10.4 mgl40 g), Legacy 60% (8.90 mgl40 g), 
~ e r s h e ~ ' s @  Dark 45% (8.72 mgl40 g), and Legacy 73.5% (8.76 mgl40 g) (Figure 17). 
The sample of Lindt 70% had a significantly larger (p<0.05) catechin concentration (10.4 
mgl40 g) than all the other chocolate samples. It may be considered unusual that a 
chocolate sample such as Hershey's@ Dark, with only 45% chocolate liquor added to the 
product, has comparable catechin concentrations to chocolates containing 60% chocolate 
liquor. Comparing Hershey's@ Dark to Legacy 60% and Ghirardelli 60%, Hershey's@ 
Dark and Legacy 60% were both processed with alkali, while Ghirardelli 60% was non- 
alkalized, which does not explain the catechin concentration differences. Perhaps the 
differences may be due to variables such as cacao tree genus, which were unknown for all 
commercial chocolates (Table 2). 
Many commercial chocolate companies use a blend of cacao beans from around 
the world (L. Lisa, personal communication, May 26,2006, R. Green, personal 
communication, June 1,2006, S. Ortiz, personal communication, May 24, 2006, & Lindt, 
2006), which implies that two to three cacao bean varieties may be blended into the 
finished chocolate product. Since the cacao tree genus (or genera) was unavailable for all 
of the commercial chocolates, no inferences can be made about the flavanol content 
regarding cacao tree genera. 
Legacy 60% was derived from the Forastero genus, while the chocolate liquor 
origin for Hershey's@ Dark and Ghiradelli were unknown (Tables 1 & 2). Since the 
Forastero genus has been noted to contain more antioxidants than the Criollo genus 
(Lopez, 2002), it may be possible that Hershey's Dark was at least partially produced 
with chocolate originating from the Forastero genus, which may explain the larger 
catechin content found in Hershey'smDark. 
Consuming chocolates with large levels of antioxidants, such as catechin, may be 
beneficial to help prevent cardiovascular diseases. In a recent study (Taubert et al. 2003), 
conducted on elderly individuals with isolated systolic hypertension, those participants 
who consumed 100g of dark chocolate per day decreased their systolic and diastolic 
blood pressure as compared to the non-chocolate control group. The consumption of 
chocolates with large levels of catechin, such as Lindt 70%, may be beneficial for 
reducing blood pressure in individuals with hypertension. 
Comparing Legacy 60% and Ghirardelli 60%, Legacy had a slightly larger mean 
concentration of catechin (8.90 mgl40 g) than Ghirardelli (7.89 mgl40 g) (Figure 17), 
although not significant (p<0.05). In addition, both Legacy 60% and Ghirardelli 60% 
were found to have significantly greater mean catechin concentrations compared to 
Legacy 41% (2.46 mgl40 g) and 58.5% (4.29 mgl40 g) (Figure 17); therefore, it may be 
difficult to attain any purported health benefits associated with chocolate consumption 
from chocolates containing a lower chocolate liquor content such as with Legacy 41% 
and 58.5%. 
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Figure 17. Mean Catechin Concentrations (mgl40 g) for all Chocolate Types.' 
Percentage of chocolate liquor. 
' Values followed by different lowercase letters are significantly different (p < 0.05). 
Figure 18 demonstrates results of epicatechin concentrations among all chocolate 
varieties. Lindt 70% had significantly larger epicatechin concentration (32.7 mgl40 g) 
than any other chocolate sampled, except for chocolate liquor (70.0 mgl40 g). 
Interestingly, Legacy 60% had a larger epicatechin concentration (29.2 mgl40 g) than 
Ghirardelli 60% (27.2 mgl40 g), and Legacy 73.5% (24.7 mgl40 g), although not 
significant (Figure 18). Chocolates with elevated percentages of chocolate liquor added to 
the finished product and smaller epichatechin concentrations than chocolates with less 
chocolate liquor added implies that other factors may affect the epicatechin 
concentration. For example, Ghirardelli 60% was not processed with alkali, while Legacy 
60% and 73.5% were alkalized (Tables 1& 2). Ghirardelli had a larger epicatechin 
concentration than Legacy 73.5%, which implies that a factor other than percent 
chocolate liquor added or alkalization processing may affect the epicatechin 
concentration, such as cacao tree genus. 
It was noted that Legacy 60% and Ghirardelli 60% had significantly greater 
epicatechin concentrations (29.2 mgl40 g and 27.2 mgI40 g, respectively) compared to 
Legacy 41 % (6.45 mgI40 g), ~ o v e '  Dark (6.56 mgl40 g), and ~ e r s h e ~ ~ s '  Dark (1 2.0 
mg/40 g) (Figure 18). Because epicatechin concentrations were significantly lower for 
Legacy 41 % and ~ o v e @  Dark as compared to all other chocolate products, these 
chocolate varieties would not be recommended for consumption to help prevent chronic 
diseases because of their low flavonoid content. 
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Figure 18. Mean Epicatechin Concentrations (mgl40 g) for all Chocolate ~ ~ ~ e s . '  
t Percentage of chocolate liquor. 
' Values followed by different lowercase letters are significantly different (p < 0.05). 
Legacy 60% and Ghirardelli 60% had similar total monomer flavanol 
concentrations (38.1 mgl40 g and 35.1 mgl40 g, respectively) (Figure 16). Even though 
Ghirardelli 60% is made with non-alkalized chocolate and Legacy 60% is made with 
alkalized chocolate (Tables 1 & 2), this finding may suggest that the total monomer 
flavanol concentration of Legacy 60% was not affected by the alkalization process or that 
the process was different for each chocolate product. 
Comparing Legacy Chocolates (excluding chocolate liquor 100%) and 
commercial brands for total monomers, Lindt 70% had the greatest mean concentration 
of total monomer flavanols (43.1 mgl40 g) (Figure 16). Lindt 70% was also found to 
have a significantly greater mean concentration of catechin (1 0.4 mgl40 g) than Legacy 
41% (2.46 mgl40 g), Legacy 58.5% (4.29 mgl40 g), and ~ o v e @  Dark 40-50% (6.27 
mgl40 g) (Figure 17). Lindt also had significantly greater epicatechin mean 
concentrations than Legacy 41 % (6.45 mgl40 g), Legacy 58.5% (1 8.4 mgl40 g), ~ o v e '  
Dark 40-50% (6.56 mgl40 g), and ~ e r s h e ~ ' s @  Dark 45% (12.0 mgl40 g) (Figure 18). 
Although no statistical difference existed for total flavanol concentrations between Lindt 
70% (43.1 mgl40 g) and Legacy 73.5% (33.4 mgl40 g) (Figure 16), Lindt 70% had a 
considerably greater total flavanol mean concentration and slightly less chocolate liquor 
added to the finished product than Legacy 73.5%. In addition, Lindt 70% was not 
processed with alkali, while Legacy 73.5% was processed with alkali; therefore, any 
flavanol differences may be attributed to alkalization processing since the percentage of 
chocolate liquor added was similar. Other chocolates with the same percentages of 
chocolate liquor added previously discussed (Ghirardelli 60% and Legacy 60%) 
demonstrated negligible differences in flavanol content between alkalized and non- 
alkalized chocolates. Differences in total flavanol content may be attributed to factors not 
observed in this study, such as cacao bean genus, cacao bean fermentation, and cacao 
bean maturity. 
The chocolates having large monomer flavanol contents, such as Lindt 70% (43.1 
mg/40 g), Legacy 60% (38.1 mgI40 g), and Ghirardelli 60% (35.1 mg/40 g) (Figure 16) 
may be beneficial for decreasing systolic blood pressure. One study (Grassi et al., 2005) 
found that the consumption of 100 g of dark chocoIate/day containing 500 mg of total 
flavonoids significantly decreased systolic blood pressure in human subjects, thereby 
decreasing the risk of cardiovascular diseases. 
Since Lindt 70% and Legacy 73.5% had large concentrations of flavanols, 
specifically epicatechin, these chocolate varieties would be ideal to consume to achieve 
the health benefits that aid in the prevention of cardiovascular diseases. It is reported that 
elevated levels of epicatechin in the blood serve as antioxidants, and are believed to 
provide a protective effect on the cardiovascular system due to their free radical 
scavenging capabilities and their ability to inhibit lipid oxidation (Wang et al., 2000). 
Wang et al. (2000) found that the consumption of 80 g of dark chocolate containing 557 
mg of total procyanidins (of which 137 mg were epicatechin) significantly increased the 
subjects mean plasma antioxidant capacity by 36% (two to six hours after consumption), 
thereby decreasing the risk of cardiovascular diseases. In the current study, the largest 
level of epicatechin was obtained from chocolate liquor (1 00%) at 70 mg/40 g (Figure 
18). Even though this level is almost half of that found by Wang et al. (2000) to elicit a 
protective effect on the cardiovascular system, it may be postulated that some plasma 
benefits could be obtained, albeit at lower levels. 
Cafeine, Legacy Chocolates, & commercial dark chocolates. Figure 19 
demonstrates results of caffeine concentrations among all chocolate varieties. Legacy 
chocolate liquor (1 00%) and Legacy 73.5% had significantly greater concentrations of 
caffeine (59.4 mgl40 g and 49.9 mgl40 g, respectively) (Figure 19) than all other 
chocolate samples. Legacy's chocolate liquor (1 00%) and Legacy 73.5% would be ideal 
chocolate products to consume in order to attain a large content of dietary caffeine; 
however, chocolate liquor is not commonly consumed due primarily to its bitter sensory 
attributes. 
In general, the statistical analyses indicated that caffeine concentrations (mgl40 g) 
of each product did not necessarily depend on the amount of chocolate liquor. For 
example, in comparison to all other chocolate samples, Legacy 60% had a caffeine 
concentration of 25.2 mgl40 g, while Ghiradelli 60% had 34.4 mgl40 g which was 
comparable to Lindt 70% that had 35.5 mgl40 g (Figure 19). This indicates that factors 
other than the percentage of chocolate liquor added to the finished product may affect the 
methylxanthine content of chocolates, such as: cacao bean genus, cacao bean 
fermentation, and cacao bean maturity. It was noted that Legacy 58.5% which had a 
significantly greater (40.7 mgl40 g) (Figure 19) caffeine content than those chocolates 
with larger chocolate liquor contents, such as Legacy 60%, Ghirardelli 60%, and Lindt 
70%, was processed with alkali and had significantly greater caffeine concentrations than 
other chocolates with similar weight percentages of chocolate liquor. Therefore, in this 
study, alkalization processing did not appear to have adversely affected caffeine 
concentrations. 
An interesting note was that Legacy 73.5% had a significantly greater mean 
caffeine concentration (49.9 mgl40 g) than Lindt 70% (35.5 mgl40 g) (Figure 19), even 
though the percentage of chocolate liquor added to each product was quite similar. It 
appears that the alkalization processing may not affect the caffeine content since Legacy 
58.5% and Legacy 73.5%, both alkalized chocolates, have significantly greater caffeine 
concentrations than non-alkalized commercial chocolates with similar percentages of 
chocolate liquor. 
According to the overall results for Legacy Chocolates, chocolates produced from 
the Criollo genus (Legacy 58.5%) had greater caffeine concentrations as compared to 
chocolates with similar percentages of chocolate liquor (Legacy 60%), which was 
produced from the Forastero genus. When comparing Legacy 58.5% and Legacy 60 %, 
Legacy 58.5% had a significantly greater caffeine concentration (40.7 mgl40 g) than 
Legacy 60% (25.2 mgl40 g) (Figure 19). Since both chocolates were processed with 
alkali, these results may be explained by the cacao tree genera: Legacy 58.5% originates 
from the Criollo genus, while Legacy 60% originates from the Forastero genus. 
Therefore, this suggests that consuming chocolate from the Criollo genus may possibly 
exhibit greater physiological stimulation (i.e., caffeine effects) than chocolate from the 
Forastero genus. 
Since Legacy 58.5%, 73.5%, and chocolate liquor (100%) had the greatest mean 
caffeine concentrations, they may impart a greater level of central nervous system 
stimulation, cardiac muscle stimulation, relaxation of smooth muscle, and diuretic effects 
as compared to other chocolate types (Apgar & Tarka, 1999; Gilbert, 2004). Studies have 
shown that caffeine consumption increases the diuretic effect, which leads to increased 
calcium loss from excretion (Massey & Whiting, 1993). Women at risk for osteoperosis 
may consider regulating their caffeine intake from chocolate because increased calcium 
excretion may be considered a potential risk factor for developing osteoporosis (Bruce & 
Spiller, 1998). Caffeine has also been implicated for causing infertility and spontaneous 
abortions (Nawrot, 2003). Although evidence is inconclusive, pregnant women are 
recommended to decrease their caffeine level to less than 300 mglday; therefore, they 
should be aware of the caffeine concentrations present in certain dark chocolates. 
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Theobromine, Legacy Chocolates, & commercial dark chocolates. Figure 20 
demonstrates the theobromine concentrations among all chocolate varieties. Legacy 
chocolate liquor (1 00%) had a significantly greater concentration of theobromine (4 14 
mgl40 g) (Figure 20) than any other chocolate. This large content of theobromine is due 
to chocolate liquor being the source of methylxanthines in dark chocolate. Legacy's 
chocolate liquor (1 00%) would be an ideal chocolate product to consume in order to 
attain a large level of dietary theobromine; however, it is not commonly consumed 
because of its bitter sensory attributes. 
Legacy 60% had the second greatest mean theobromine concentration (302 mgl40 
g) (Figure 20), which was significantly greater than the other Legacy and commercial 
brands. When comparing Legacy 60% and Legacy 58.5% (both having similar levels of 
chocolate liquor), Legacy 60%, it was noted to have a significantly greater theobromine 
concentration (302 mgl40 g) than Legacy 58.5% (160 mgl40 g) (Figure 20). The 
differences in theobromine concentrations between the two Legacy chocolates both 
processed with alkali and containing similar percentages of chocolate liquor may be 
attributed to the cacao tree genera: the Forastero genus has a greater theobromine 
concentration compared to the Criollo genus. Legacy 60% was from the Forastero genus, 
while Legacy 58.5% was from the Criollo genus. However, other factors that may also 
influence the theobromine concentration, such as cacao bean fermentation and cacao bean 
maturity, both of which were not investigated in this study, warrant further investigation. 
Lindt 70% had third greatest theobromine concentration (284 mgl40 g), which 
was significantly greater than all other chocolates except Legacy 60% (327 mgl40 g) and 
Legacy chocolate liquor (loo%), (473 mgl40 g), (Figure 20). These results indicate that 
dark chocolates with large theobromine concentrations such as Legacy 60% and Lindt 
70% may be beneficial since their ingestion may exhibit anti-cough properties by 
inhibiting sensory nerve functions as demonstrated previously in one study (Usmani et 
al., 2004). In this study, it has been noted that concentrations of dietary theobromine 
ranging from 500 mg to 1000 mg are associated with displaying a bronchodilator effect in 
human subjects (Usmani et al., 2004). 
Lindt 70 % (284 mgl40 g) had a significantly greater theobromine concentration 
when compared to Legacy 73.5% (207 mgl40 g), and Legacy 60% (302 mgl40 g) had a 
significantly greater theobromine concentration when compared to Ghirardelli 60% (206 
mgl40 g) (Figure 20). Even though the percentage of chocolate liquor added to the 
compared samples is similar, and the theobromine varies between them, other factors 
may be contributing to the differences in the theobromine concentration. For instance, 
Lindt 70% and Ghirardelli 60% were not processed with alkali, while Legacy 60% and 
Legacy 73.5% were processed with alkali. Comparing Lindt 70% and Legacy 73.5%, it 
was found that Lindt 70%, a non-alkalized chocolate, contained a significantly greater 
theobromine concentration than Legacy 73.5%, an alkalized chocolate. However, 
comparing Legacy 60% and Ghirardelli 60%, Legacy 60% (an alkalized chocolate) had a 
significantly greater theobromine concentration than Ghirardelli 60% (a non-alkalized 
chocolate). This conflicting evidence may suggest that alkalization does not play a 
significant role in reducing the theobromine content in chocolates with similar 
percentages of chocolate liquor. The differences may be explained by other factors, such 
as cacao bean genera, cacao bean fermentation, or cacao bean maturity. Therefore, more 
studies need to be conducted in order to determine the difference in theobromine content 











cd 2 250- 
a 
0 





2 loo- + 
50- 




63 Legacy 58.5%t 
El Legacy 60%t 





Figure 20. Mean Theobromine Concentrations (mgl40g) for all Chocolate ~ p e s . '  
7 Percentage of chocolate liquor. 
Values followed by different lowercase letters are significantly different (p < 0.05). 
Chapter V: Conclusion 
The purpose of this study was to identify and quantify monomer flavanols and 
methylxanthines in chocolates obtained from Legacy Chocolates with different weight 
percentages of chocolate liquor and to then compare these findings to commercially 
available dark cliocolates. Flavanols and methylxanthines were extracted from the 
chocolate samples and analyzed by HPLC. The concentrations of each compound were 
calculated per 40 gram sample for comparison to health effects attained from human 
studies. 
Statistical analysis was performed on catechin, epicatechin, caffeine, and 
theobromine concentrations (mg/40 g serving size) to determine if differences existed 
between the weight percent of chocolate liquor added to each product, flavanol content, 
and methylxanthine content. 
The cacao bean genera were unknown blends for all of the commercial products, 
and known for Legacy chocolates. No information was known concerning the cacao bean 
fermentation processes used for any of the chocolates. The only commercial chocolates 
known to contain alkalized chocolate liquor were ~ e r s h e ~ ' s @  and ~ o v e @ ,  while all 
Legacy products were processed with alkali. 
In general, the greater percentage of chocolate liquor added to a chocolate 
product, the greater the flavanol content. However, this study demonstrated that other 
factors can also influence the total flavanol content. One know factor that demonstrated 
its influence on flavanol concentrations in this study was cacao tree genus. For example, 
when comparing the flavanol content of Legacy 60% and 58.5%, Legacy 60% had a 
significantly greater concentration than Legacy 58.5%. Since the percent of chocolate 
liquor added was very similar and both chocolates were processed with alkali, the only 
other known factor was the different cacao tree genera, implying that the Forastero genus 
contains more flavanols than the Criollo genus. Although other factors such as cacao 
bean fermentation and cacao bean maturity can affect the flavanol content, not enough 
information about these two factors was known for the chocolate products analyzed to 
draw definite conclusions on flavanol differences. 
To achieve the flavanol antioxidant health benefits from dark chocolate 
consumption reported in this study, it would be recommended to consume dark chocolate 
with a large percent of chocolate liquor from the Forastero genus. Typically, the cacao 
tree genus information is not readily available for consumers. Many of the studies 
previously discussed involved consuming between 40-100 g of dark chocolatelday to 
achieve health benefits that prevent the development of chronic diseases. For many 
people, this recommended quantity of chocolate would be difficult to consume on a daily 
basis. However, dark chocolate could be incorporated into a healthy diet that includes 
flavonoids from different plant sources. 
According to the results for Legacy Chocolates, the percentage of chocolate liquor 
added and tree genera had opposite influences on the caffeine and theobromine content. 
For caffeine, the chocolates with the greatest percent of chocolate liquor from the Criollo 
genus had the greatest caffeine content as compared to the Forastero genus. Conversely, 
the Criollo genus had the lowest theobromine concentrations, while the Forastero genus 
had the greatest. More studies need to be conducted to determine what effects cacao bean 
fermentation, cacao bean maturity, and alkalization have on caffeine and theobromine 
concentrations in dark chocolates. 
Methylxanthines produce many stimulatory physiological effects in the body. 
Many people regulate their caffeineltheobromine intake to avoid these health effects. To 
avoid some of the stimulatory effects of caffeine and still attain the antioxidant health 
effects of the flavonoid polyphenols, it would be advised to consume dark chocolate from 
the Forastero genus. The Forastero genus has less caffeine per serving in chocolates with 
similar percentages of chocolate liquor compared to the Criollo genus. 
This study demonstrated that dark chocolate is an excellent source of flavanols 
and methylxanthines. Chocolate consumers should be aware of the factors studied in this 
experiment that can influence the polyphenol and methylxanthine concentration in 
chocolates, such as the percentage of chocolate liquor added to the finished product and 
cacao tree genus. From the results of this study, it is recommended to consume chocolates 
with an elevated percentage of chocolate liquor (60% or more) from the Forastero genus 
to attain health benefits from flavanols that are commonly associated with chocolate 
consumption. 
Recommendations 
The following research is suggested to further explore the 
flavonoidJmethylxanthine content of chocolate products available from Legacy 
Chocolates: 
1) QuantifL the flavanol/methylxanthine content of the truffle ganache to calculate 
the total concentration per truffle. 
2) Quantify the flavanol/methylxanthine content of the 85% chocolate (made from 
73.5% + 100% chocolate liquor). 
3) Identify and quantify other polyphenols/flavonoids present from the addition of 
merlot wine and green tea in the merlot and green tea truffles. 
4) Identify and quantify chocolate procyanidins present in the chocolates containing 
different percentages of chocolate liquor by HPLC and MS. 
5) Determine the affect of alkalization on flavonoid/methylxanthine concentrations 
in dark chocolates by comparing chocolates with the same percentage of 
chocolate liquor from the same known cacao tree genus, alkalized and non- 
alkalized. 
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